Implantation of flexible implant

Description

FIELD OF THE INVENTION

The present invention relates in general to valve repair, and more specifically to repair of an atrioventricular valve of a patient.

BACKGROUND OF THE INVENTION

Ischemic heart disease causes mitral regurgitation by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the left ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the mitral valve annulus.

Dilation of the annulus of the mitral valve prevents the valve leaflets from fully coapting when the valve is closed. Mitral regurgitation of blood from the left ventricle into the left atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the left ventricle secondary to a volume overload and a pressure overload of the left atrium.

SUMMARY OF THE INVENTION

In some embodiments of the present invention, an adjustable annuloplasty structure is provided for repairing a dilated valve annulus of an atrioventricular valve, such as a mitral valve. The annuloplasty structure comprises a flexible sleeve and a plurality of anchors. An anchor deployment manipulator is advanced into a lumen of the sleeve, and, from within the lumen, deploys the anchors through a wall of the sleeve and into cardiac tissue, thereby anchoring the sleeve around a portion of the valve annulus. The anchors are typically deployed from a distal end of the manipulator while the distal end is positioned such that a central longitudinal axis through the distal end of the manipulator forms an angle with a surface of the cardiac tissue of between about 20 and 90 degrees, e.g., between about 45 and 90 degrees, e.g., between about 75 and 90 degrees, such as about 90 degrees. Typically, the anchors are deployed from the distal end of the manipulator into the cardiac tissue in a direction parallel to the central longitudinal axis through the distal end of the manipulator.

A multi-component tubular system is provided for accessing a heart of a patient. The system comprises one or more steerable guiding catheters configured for directing the passage of devices therethrough into the heart. The multi-component tubular system is configured to deliver an implant in a desired orientation to an annulus of a cardiac valve of the patient and to facilitate anchoring of the implant to the annulus. For some applications of the present invention, the guiding system is advanced transluminally or transthoracically accessing an atrium of the heart. Typically, the system comprises two or more steerable catheters. A first catheter has a distal portion that is steerable to a first desired spatial orientation. A second catheter is disposed within the first catheter and has a distal portion that is steerable to a second desired spatial orientation.

Typically, the annuloplasty structure comprises a sleeve with an elongated tubular wall and at least one end wall having a surface substantially transverse to a lateral surface of the tubular wall. A method is provided for deploying a first tissue anchor through the surface of the end wall of the sleeve and into annulus tissue and subsequently deploying a second tissue anchor through the tubular wall. The first tissue anchor and the second tissue anchor are both deployed consecutively to extend in a substantially same direction and into a common, substantially planar surface of a valve annulus. That is, the first and second tissue anchors are deployed in succession with no intervening anchor between the anchors, and a distance between the anchors is between 2.5 and 15 mm, e.g., between 2.5 and 9 mm, e.g., 8 mm.

The first and second anchors extend in the substantially same direction despite that the first tissue anchor is deployed through the end wall transverse to the side wall. That is, the first and second anchors extend in the substantially same direction while the first tissue anchor is deployed through the end wall transverse to the side wall.

In such a deployment, a distal end portion of the sleeve between the first and second tissue anchors is formed into a substantial “U”-shaped portion having a concavity facing the tissue of the annulus.

There is therefore provided, in accordance with some applications of the present invention, a method of deploying an annuloplasty structure, the method including:

introducing into a heart atrium, the annuloplasty structure having a sleeve with an elongated tubular side wall and at least one distal end wall having a surface substantially transverse to a lateral surface of the tubular side wall;

deploying a first tissue anchor through the surface of the end wall of the sleeve and into a first portion of annulus tissue; and

deploying a second tissue anchor through a portion of the tubular side wall and into a second portion of annulus tissue, such that the first tissue anchor and the second tissue anchor are both deployed consecutively, to extend in a substantially same direction and into a common, substantially planar surface of a valve annulus, the common, substantially planar surface including the first and second portions of the annulus tissue.

In some applications of the present invention, deploying the second tissue anchor includes deploying the second tissue anchor between 2.5 and 15 mm from the first tissue anchor.

In some applications of the present invention, deploying the second tissue anchor includes deploying the second tissue anchor between 2.5 and 9 mm from the first tissue anchor.

In some applications of the present invention, deploying the second tissue anchor through the tubular wall includes deploying the second tissue anchor substantially parallel with respect to the first tissue anchor.

In some applications of the present invention, deploying the second tissue anchor through the tubular wall includes deploying the second tissue anchor between 0 and 45 degrees with respect to the first tissue anchor.

In some applications of the present invention, deploying the second tissue anchor through the tubular wall, includes deploying the second tissue anchor between 0 and 20 degrees with respect to the first tissue anchor.

In some applications of the present invention, deploying the second tissue anchor includes forming a portion of the sleeve between the first and second tissue anchors into a substantially “U”-shaped portion.

In some applications of the present invention, deploying the first anchor includes deploying the first anchor from a distal end of a deployment manipulator through the surface of the end wall of the sleeve into the cardiac tissue, while the distal end of the deployment manipulator is positioned such that a central longitudinal axis through the distal end of the deployment manipulator forms an angle of between 20 and 90 degrees with the distal end wall of the sleeve at a point at which the first anchor penetrates the end wall.

In some applications of the present invention, deploying the first anchor includes deploying the first anchor from a distal end of a deployment manipulator through the surface of the end wall of the sleeve into the cardiac tissue, while the distal end of the deployment manipulator is positioned such that a central longitudinal axis through the distal end of the deployment manipulator forms an angle of between 45 and 90 degrees with the distal end wall of the sleeve at a point at which the first anchor penetrates the end wall.

In some applications of the present invention, deploying the second anchor includes deploying the second anchor from a distal end of a deployment manipulator through the surface of the portion of the tubular wall of the sleeve into the cardiac tissue, while the distal end of the deployment manipulator is positioned such that a central longitudinal axis through the distal end of the deployment manipulator forms an angle of between 20 and 90 degrees with the portion of the tubular wall of the sleeve at a point at which the second anchor penetrates the portion of the tubular wall.

In some applications of the present invention, deploying the second anchor includes deploying the second anchor from a distal end of a deployment manipulator through the surface of the portion of the tubular wall of the sleeve into the cardiac tissue, while the distal end of the deployment manipulator is positioned such that a central longitudinal axis through the distal end of the deployment manipulator forms an angle of between 45 and 90 degrees with the portion of the tubular wall of the sleeve at a point at which the second anchor penetrates the portion of the tubular wall.

In some applications of the present invention, deploying the first anchor includes deploying the first anchor through a channel disposed within a lumen of the sleeve, the channel having a distal end defining an opening through with the first anchor passes, and deploying the first anchor includes sandwiching the surface of the end wall of the sleeve between the distal end of the channel and the first portion of annulus tissue.

In some applications of the present invention, sandwiching includes positioning the distal end of the channel in a manner in which the distal end of the channel is aligned substantially parallel to the planar surface.

In some applications of the present invention, deploying the second anchor includes deploying the second anchor through a channel disposed within a lumen of the sleeve, the channel having a distal end defining an opening through with the second anchor passes, and deploying the second anchor includes sandwiching the portion of the tubular side wall of the sleeve between the distal end of the channel and the second portion of annulus tissue.

In some applications of the present invention, deploying the second tissue anchor includes forming a portion of the sleeve between the first and second tissue anchors into an arc with a concave surface facing the annulus tissue.

In some applications of the present invention, the method further includes forming a distal portion of the sleeve between the first and second tissue anchors into a shape.

In some applications of the present invention, forming the distal portion of the sleeve into the shape includes forming the distal portion of the sleeve into the shape prior to the deploying of the second anchor by flexing the distal portion of the sleeve.

In some applications of the present invention, forming the distal portion of the sleeve into the shape includes forming the distal portion of the sleeve into the shape responsively to the deploying of the second anchor.

In some applications of the present invention, the annuloplasty structure includes a stiffener configured to bias the annuloplasty structure into the shape.

In some applications of the present invention, forming the distal portion of the sleeve into the shape includes forming the distal portion of the sleeve into a shape in which:

a first part of the lateral surface of the tubular side wall is positioned close to the tissue of the annulus,

a second part of the lateral surface of the tubular side wall is disposed opposite the first part of the lateral surface of the tubular side wall and away from the tissue of the annulus, and

the second part of the lateral surface of the tubular side wall has a degree of tension that is larger than a degree of tension of the first part of the lateral surface of the tubular side.

In some applications of the present invention, the first part of the lateral surface of the tubular side wall is ruffled and is disposed adjacent the tissue of the annulus.

In some applications of the present invention, forming the distal portion of the sleeve into the shape includes forming the distal portion of the sleeve into a shape having a concavity.

In some applications of the present invention, forming the distal portion of the sleeve into the shape having the concavity includes creating a gap between the distal portion of the sleeve and the annulus tissue, the gap having a longest distance between 0.2 and 7.5 mm.

In some applications of the present invention, forming the portion of the sleeve into the shape having the concavity includes creating a gap between the portion and the annulus tissue, the gap having a longest distance between 0.5 and 3 mm.

In some applications of the present invention, the method further includes, following the deploying the first tissue anchor, flexing the annuloplasty structure while the distal end wall is anchored, to form a concave shape of the structure between (a) a portion of the structure proximal to the distal end wall of the structure, and (b) the annulus, deploying the second tissue anchor includes maintaining the concave shape during the deploying.

In some applications of the present invention, deploying the first tissue anchor and deploying the second tissue anchor includes deploying the first and second tissue anchors from within a lumen of a channel disposed within a lumen of the sleeve while at least a proximal portion of the sleeve is surrounded by a catheter.

In some applications of the present invention, the valve is a mitral valve.

There is also provided, in accordance with some applications of the present invention, a method of repairing a cardiac valve, the method including:

introducing into a heart atrium, a flexible annuloplasty structure having a sleeve with an elongated tubular side wall and at least one distal end wall having a surface substantially transverse to a lateral surface of the tubular side wall;

anchoring the distal end wall of the sleeve to a valve annulus on an atrial surface of the valve by deploying a first tissue anchor;

while the distal end wall is anchored, positioning alongside the valve annulus a portion of the tubular side wall that is proximal to the distal end wall in a manner in which the portion of the tubular side wall assumes a shape in which:

- a first part of the lateral surface of the tubular side wall is positioned close to the tissue of the annulus,
- a second part of the lateral surface of the tubular side wall is disposed opposite the first part of the lateral surface of the tubular side wall and away from the tissue of the annulus, and
- the second part of the lateral surface of the tubular side wall has a degree of tension that is larger than a degree of tension of the first part of the lateral surface of the tubular side;

anchoring the portion of the tubular side wall to the annulus by deploying a second tissue anchor consecutively to the first tissue anchor; and

continuing to position the annuloplasty structure about a circumference of the atrial surface of the annulus while periodically anchoring additional locations of the tubular side wall of the sleeve to the atrial surface of the annulus.

There is additionally provided, in accordance with some applications of the present invention, apparatus for repairing a cardiac valve, the apparatus including:

a flexible annuloplasty structure having a sleeve with an elongated tubular side wall and at least one distal end wall having a surface substantially transverse to a lateral surface of the tubular side wall;

a first tissue anchor passing through the distal end wall of the sleeve; and

a second tissue anchor passing through the tubular side wall, the first and second tissue anchors being disposed consecutively and to extend in a substantially same direction.

There is further provided, in accordance with some applications of the present invention, apparatus for repairing a cardiac valve, the apparatus including:

a first tissue anchor passing through the distal end wall of the sleeve; and

a second tissue anchor passing through the tubular side wall in a manner in which a portion of the tubular side wall that is between the first and second tissue anchors assumes a shape in which:

- the portion has a first part of the lateral surface of the tubular side wall and a second part of the lateral surface of the tubular side wall opposite the first part, and
- the second part of the lateral surface of the tubular side wall has a degree of tension that is larger than a degree of tension of the first part of the lateral surface of the tubular side wall.

There is yet additionally provided, in accordance with some applications of the present invention, a method of repairing a cardiac valve, the method including:

introducing into a heart atrium, an annuloplasty structure having a sleeve with an elongated tubular side wall and at least one distal end wall having a surface substantially transverse to a lateral surface of the tubular side wall;

anchoring, using a first tissue anchor, the distal end wall of the sleeve to a valve annulus on an atrial surface of the valve;

forming a concave shape of a distal portion of the structure between the distal end portion of the structure and the annulus by positioning the tubular side wall in a vicinity of the valve annulus by flexing the annuloplasty structure while the distal end wall is anchored;

anchoring, using a second tissue anchor, a distal portion of the tubular side wall of the sleeve to the annulus, such that when the first tissue anchor and the second tissue anchor are anchored, the concave shape is maintained along the distal portion of the structure; and

The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic illustration of an annuloplasty ring structure, comprising a sleeve and an adjusting mechanism, in accordance with some applications of the invention;

FIG. 2 is a schematic illustration of a multi-component tubular system for delivering and anchoring an implant and for controlling a relative spatial orientation of components of the catheter system, in accordance with some applications of the present invention;

FIGS. 3A-C are schematic illustrations of an annuloplasty ring structure comprising a sleeve and an adjusting mechanism, in accordance with some applications of the invention;

FIGS. 4A-G are schematic illustrations of steps in the implantation of an annuloplasty ring structure to repair a mitral valve, in accordance with some applications of the invention;

FIG. 5 is a schematic illustration of a state of a distal portion of a multi-component tubular system within the heart of a subject, in accordance with some applications of the invention;

FIGS. 6A-C are schematic illustrations of a tissue anchor, in accordance with some applications of the present invention; and

FIG. 7 is a schematic illustration of a step in the implantation of an annuloplasty ring structure to repair a mitral valve, in accordance with some applications of the invention.

DETAILED DESCRIPTION OF EMBODIMENTS

Reference is now made to FIGS. 1-2, which are schematic illustrations of a multi-component tubular system 10 providing one or more rotationally-controlled steering catheters configured for delivering an implant to a heart of a patient, in accordance with some applications of the present invention.

FIG. 1 shows a distal portion of an implant comprises an annuloplasty ring structure 222 (e.g., an annuloplasty band) comprising a flexible sleeve 26 (shown in the exploded view of FIG. 2). Sleeve 26 typically comprises a braided fabric mesh, e.g., comprising DACRON™. Sleeve 26 is typically configured to be placed only partially around a cardiac valve annulus (i.e., to assume a C-shape), and, once anchored in place, to be contracted so as to circumferentially tighten the valve annulus. Alternatively, the ring structure is configured to be placed entirely around the valve annulus.

Sleeve 26 has an elongated lateral tubular side wall 253 and at least one end wall 251 (e.g., a distal end wall) having a surface that is substantially transverse to a lateral surface of tubular wall 253. Typically, end wall 251 defines an end wall of annuloplasty ring structure 222.

In order to tighten the annulus, annuloplasty ring structure 222 comprises a flexible elongated contracting member 226 that extends along sleeve 26. Elongated contracting member 226 comprises a wire, a ribbon, a rope, or a band, which typically comprises a flexible and/or superelastic material, e.g., nitinol, polyester, stainless steel, or cobalt chrome. For some applications, the wire comprises a radiopaque material. For some applications, contracting member 226 comprises a braided polyester suture (e.g., Micron). For some applications, contracting member 226 is coated with polytetrafluoroethylene (PTFE). For some applications, contracting member 226 comprises a plurality of wires that are intertwined to form a rope structure.

Annuloplasty ring structure 222 further comprises an adjustment mechanism 40, which facilitates contracting and expanding of annuloplasty ring structure 222 so as to facilitate adjusting of a perimeter of the annulus and leaflets of the cardiac valve. Adjustment mechanism 40 is described in more detail hereinbelow. Adjustment mechanism 40 comprises a rotatable structure (e.g., a spool, as described hereinbelow) that is disposed within a housing 44. As shown in the enlarged image of FIG. 1, adjustment mechanism 40 is surrounded by a braided mesh and is coupled (e.g., by being sutured or otherwise coupled) to the braided mesh of sleeve 26. For some applications, adjustment mechanism 40 is coupled to an outer, lateral surface of sleeve 26.

Reference is now made to FIG. 2, which shows the concentric relationship between components of tubular system 10 (in an exploded view on the left side of FIG. 2). System 10 comprises an implant-delivery tool. Typically, system 10 comprises a first, outer catheter 12 comprising a sheath configured for advancement through vasculature of a patient. For some applications of the present invention, outer catheter 12 comprises a sheath configured for advancement through a femoral artery toward an interatrial septum of a heart of a patient. A distal steerable end portion of outer catheter 12 is configured to pass through the septum and be oriented in a desired spatial orientation. System 10 comprises a second catheter, or guide catheter 14, comprising a steerable distal end portion. Catheter 14 is configured for advancement through a lumen of outer catheter 12.

A distal end portion of outer catheter 12 is steerable. The distal end portion of outer catheter 12 comprises a pull ring 11 that is coupled to two or more pull wires 29a and 29b, that are disposed within respective secondary lumens within a wall of catheter 12 (as shown in section A-A). As shown in the exploded view, guide catheter 14 is configured to be concentrically disposed within the lumen of catheter 12. As described hereinabove, the distal end portion of guide catheter 14 is steerable. The distal end portion of catheter 14 comprises a pull ring 13 that is coupled to two or more pull wires 31a and 31b, that are disposed within respective secondary lumens within a wall of catheter 14 (as shown in sections A-A and B-B).

Guide catheter 14 is steerable to a desired spatial orientation in order to facilitate advancing and implantation of an implant in a body cavity of the patient.

For applications in which system 10 is used to deliver an implant to the mitral valve of the patient, typically, outer catheter 12 is configured for initial advancement through vasculature of the patient until a distal end 102 of catheter 12 is positioned in the left atrium. The distal steerable end portion of catheter 12 is then steered such that distal end 102 of catheter 12 is positioned in a desired spatial orientation within the left atrium. The steering procedure is typically performed with the aid of imaging, such as fluoroscopy, transesophageal echo, and/or echocardiography. Following the steering of the distal end portion of catheter 12, guide catheter 14 (which houses annuloplasty ring structure 222) is advanced through catheter 12 in order to facilitate delivery and implantation of structure 222 along the annulus of the mitral valve. During the delivery, at least a portion of the steerable distal end portion of catheter 14 is exposed from distal end 102 of catheter 12 and is thus free for steering toward the annulus of the mitral valve, as is described hereinbelow.

During delivery of sleeve 26 to the annulus of the cardiac valve, sleeve 26 and mechanism 40 are disposed within a lumen of catheter 14 and are aligned longitudinally with a longitudinal lumen of catheter 14. Such coupling of mechanism 40 to sleeve 26 allows mechanism 40 to transition from a state in which it is in line with the longitudinal axis of catheter 14 (FIG. 2) to a state in which it is disposed alongside sleeve 26 (FIG. 3C, shown hereinbelow). The positioning of adjustment mechanism 40 alongside a portion of sleeve 26 exposes a driving interface of the rotational structure to be accessed by a rotational tool that is guided toward adjustment mechanism 40 via a guide member 86.

Reference is again made to FIG. 1. A flexible, longitudinal guide member 86 (e.g., a wire) is coupled to a portion of adjustment mechanism 40 (e.g., a portion of the rotatable structure, as described hereinbelow). Guide member 86 is configured to facilitate guiding of a rotational tool via guide member 86 and toward the rotatable structure of adjustment mechanism 40. Typically, the rotational tool is configured to engage the rotatable structure of adjustment mechanism 40 following implantation of sleeve 26 along the annulus of the cardiac valve. Guide member 86 passes from adjustment mechanism 40, alongside a portion of the distal end portion of guide catheter 14, and into a secondary lumen in the wall of guide catheter 14, through an opening 15 in guide catheter 14. Guide member 86 passes through the secondary lumen of guide catheter 14 (as shown in sections A-A and B-B in FIG. 2) and has a proximal end that is accessible from outside the body of the patient. The secondary lumen in the wall of guide catheter 14 facilitates passage of guide member 86 through system 10 without interfering with the other concentrically-disposed elongate tubular members that pass concentrically through the lumen of guide catheter 14.

Reference is again made to FIG. 2. In addition, system 10 comprises a plurality of anchors 32, typically between about 5 and about 20 anchors, such as about 10 or about 16 anchors. Each anchor 32 comprises a tissue coupling element 60 (e.g., a helical tissue coupling element), and a tool-engaging head 62 (e.g., a non-helically-shaped portion), fixed to one end of the tissue coupling element. Only one anchor 32 is shown in FIG. 2 as being reversibly coupled to a deployment element 38 of a rotating anchor driver 36 of an anchor deployment manipulator 61. When sleeve 26 is disposed along the annulus of the cardiac valve, deployment manipulator 61 is configured to advance within a lumen of sleeve 26 and deploy each anchor 32 from within sleeve 26 through a wall of sleeve 26 and into cardiac tissue, thereby anchoring sleeve 26 around a portion of the valve annulus. The insertion of the anchors into the sleeve and deployment of the anchors into cardiac tissue is described in detail hereinbelow.

Typically, but not necessarily, anchors 32 comprise a biocompatible material such as stainless steel 316 LVM. For some applications, anchors 32 comprise nitinol. For some applications, anchors 32 are coated fully or partially with a non-conductive material.

Deployment manipulator 61 comprises anchor driver 36 and deployment element 38. For some applications, deployment manipulator 61 comprises channel 18.

As shown in the exploded view of FIG. 2, sleeve 26 is disposed within a lumen of guide catheter 14. A force is applied to a proximal end of sleeve 26 is by a distal end of a reference-force tube 19. As shown, an implant-decoupling channel 18 is advanceable within a lumen of reference-force tube 19 and through a lumen of sleeve 26. As shown in the enlarged image of FIG. 1, a distal end 17 of implant-decoupling channel 18 is disposed in contact with an inner wall of sleeve 26 at a distal end thereof. Additionally, a distal end portion of channel 18 comprises a radiopaque marker 1018. As shown, tube 19 and sleeve 26 are longitudinally and coaxially disposed with respect to each other.

For some applications, channel 18 is steerable.

Typically, manipulator 61 advances within channel 18. For some applications, system 10 comprises a plurality of anchor drivers 36 of manipulator 61, each driver 36 being coupled to a respective anchor 32. Each driver 36 is advanced within channel 18 in order to advance and implant anchor 32 in tissue. Following implantation of anchor 32, anchor 32 is decoupled from driver 36, as described herein, and driver 36 is removed from within channel 18. Subsequently, a new driver 36 coupled to another anchor 32 is then advanced within channel 18.

As will be described hereinbelow, a first one of anchors 32 is configured to be deployed through end wall 251 of sleeve 26 into cardiac tissue, when sleeve 26 is positioned along the annulus of the valve. Following the deployment of the first tissue anchor, a distal portion of sleeve 26 is slid distally off a portion of implant-decoupling channel 18. In order to decouple sleeve 26 distally from a portion of outer surface of channel 18, (1) a proximal force is applied to channel 18, while (2) reference-force tube 19 is maintained in place in a manner in which a distal end of tube 19 provides a reference force to sleeve 26 in order to facilitate freeing of a successive portion of sleeve 26 from around channel 18. Channel 18 is then positioned at a successive location within the lumen of sleeve 26 while either tube 19 and/or catheter 14 is steered toward a successive location along the annulus of the valve (as will be described hereinbelow). Consequently, the successive portion of sleeve 26 provides a free lumen for advancement of a successive anchor 32 and deployment of the anchor through the wall of the sleeve at the successive portion thereof. Such freeing of the successive portion of sleeve 26 creates a distance between successive anchors deployed from within the lumen of sleeve 26.

For some applications, sleeve 26 comprises a plurality of radiopaque markers 25, which are positioned along the sleeve at respective longitudinal sites. The markers may provide an indication in a radiographic image (such as a fluoroscopy image) of how much of the sleeve has been deployed at any given point during an implantation procedure, in order to enable setting a desired distance between anchors 32 along the sleeve. For some applications, the markers comprise a radiopaque ink.

Typically, at least a portion (e.g., at least three, such as all) of the longitudinal sites are longitudinally spaced at a constant interval. Typically, the longitudinal distance between the distal edges of adjacent/consecutive markers, and/or the distance between the proximal edges of adjacent markers, is set equal to the desired distance between adjacent anchors. For example, the markers may comprise first, second, and third markers, which first and second markers are adjacent, and which second and third markers are adjacent, and the distance between the proximal and/or distal edges of the first and second markers equal the corresponding distance between the proximal and/or distal edges of the second and third markers. For example, the distance may be between 3 and 15 mm, such as 6 mm, and the longitudinal length of each marker may be between 0.1 and 14 mm, such as 2 mm. (If, for example, the distance were 6 mm and the length were 2 mm, the longitudinal gaps between adjacent markers would have lengths of 4 mm.)

Each anchor 32 is coupled to deployment element 38 of anchor driver 36. Anchor driver 36 comprises an elongate tube having at least a flexible distal end portion. The elongate tube of driver 36 extends within a lumen of channel 18, through system 10 toward a proximal end of a proximal handle portion 101 of system 10. The tube of anchor driver 36 provides a lumen for slidable advancement therethrough of an elongate rod 130. Rod 130 facilitates the locking and unlocking of anchor 32 to deployment element 38. As shown in Section E-E of FIG. 2, a proximal end of rod 130 is coupled to a component of an anchor-release mechanism 28 at a proximal end of system 10. Mechanism 28 comprises a housing 135 and a finger-engager 131 that is coupled to the proximal end of rod 130. Finger-engager 131 is coupled to a housing 135 via a spring 133 (section E-E of FIG. 2). A proximal end of the tube of anchor driver 36 is coupled to housing 135. As is described hereinbelow, the physician releases anchor 32 from deployment element 38 when finger-engager 131 is pulled proximally, thereby pulling rod 130 proximally.

Proximal handle portion 101 is supported by a stand having support legs 91 and a handle-sliding track 90. Handle portion 101 comprises an outer-catheter handle 22, a guide-catheter handle 24, an implant-manipulating handle 126, and anchor-release mechanism 28. Handle 22 is coupled to a proximal end of outer catheter 12. Handle 24 is coupled to a proximal portion of guide catheter 14. Handle 126 is coupled to a proximal portion of reference-force tube 19, and linear movement of handle 126 with respect to handle 24 moves reference-force tube 19 (and thereby typically structure 222) through catheter 14. As described hereinabove, housing 135 of anchor-release mechanism 28 is coupled to a proximal portion of the tube of anchor driver 36. The relative positioning of each of the concentrically-disposed components of system 10 is shown in the exploded view and sections A-A, B-B, C-C, and D-D of FIG. 2.

The stand supporting proximal handle portion 101 may be moved distally and proximally to control a position of the entire multi-component system 10, particularly so as to adjust a distance of distal end 102 of catheter 12 from the interatrial septum. Handle 22 comprises a steering knob 210 that is coupled to steering wires 29a and 29b disposed within respective secondary lumens in the wall of outer catheter 12. Rotation of knob 210 adjusts a degree of tension of wires 29a and 29b which, in turn, apply a force to pull ring 11 at the distal end portion of outer catheter 12. Such force steers the distal end portion of catheter 12 within the atrium of the heart of the patient in a manner in which the distal end portion of catheter 12 is steered in a first plane that is parallel with the plane of the annulus of the valve (e.g., in a direction from the interatrial septum toward surrounding walls of the atrium). For some applications of the present invention, the distal end portion of catheter 12 may be pre-shaped so as to point downward toward the valve. For other applications, the distal end portion of catheter 12 may be pulled to assume an orientation in which the distal end portion points downward toward the valve. For yet other applications of the present invention, the distal end portion of catheter 12 is not made to point downward toward the valve.

Handle 24 is coupled to track 90 via a first mount 92. Mount 92 is slidable proximally and distally along track 90 in order to control an axial position of guide catheter 14 with respect to outer catheter 12. Mount 92 is slidable via a control knob 216. For example, control knob 216 of mount 92 controls the proximal and distal axial movement of the distal steerable portion of guide catheter 14 with respect to distal end 102 of outer catheter 12. Handle 24 comprises a steering knob 214 that is coupled to steering wires 31a and 31b disposed within respective secondary lumens in the wall of guide catheter 14. Rotation of knob 214 adjusts a degree of tension of wires 31a and 31b which, in turn, apply a force to pull ring 13 at the distal end portion of guide catheter 14. Such force steers the distal end portion of catheter 14 in a second plane within the atrium of the heart of the patient downward and toward the annulus of the cardiac valve. Typically, as described hereinbelow, the distal end portion of guide catheter 14 is steered in the second plane that is substantially perpendicular with respect to the first plane in which the distal end portion of outer catheter 12 is steered.

The combined steering of the respective distal end portions of catheters 12 and 14 directs sleeve 26 down toward the annulus (e.g., via the steering of the distal end portion of catheter 14) and along the perimeter of annulus (e.g., from the posterior section of the valve to the anterior section of the valve, and vice versa), via the steering of the distal end portion of catheter 12.

For some applications, handle 22 may be tilted by the operating physician, in order to further adjust a position of the distal end of catheter 12.

Handle 126 is coupled to track 90 via a second mount 93. Mount 93 is slidable proximally and distally along track 90, in order to control an axial position of reference-force tube 19 and at least a proximal portion of sleeve 26 with respect to guide catheter 14. Mount 93 is slidable via a control knob 95. For example, control knob 95 of mount 93 controls the proximal and distal axial movement of the tube 19 and at least the proximal portion of sleeve 26 with respect to distal end 104 of guide catheter 14. Taken together with the steering of the distal end portion of guide catheter 14, such movement of tube 19 and at least the proximal portion sleeve 26 moves the proximal portion of sleeve 26 toward a desired portion of tissue of the annulus of the valve during deployment of anchors 32 from within the lumen of sleeve 26, as is described hereinbelow.

As is described hereinabove, in order to decouple sleeve 26 from a portion of an outer surface of channel 18, (1) channel 18 is pulled proximally, while (2) reference-force tube 19 is maintained in place. A proximal end of channel 18 is coupled to a knob 94 which adjusts an axial position of channel 18 proximally and distally with respect to reference-force tube 19 and sleeve 26.

Typically, handle portion 101 comprises a release decision facilitation member 127, such as a latch or button, that automatically engages when a given length of sleeve 26 has advanced off channel 18 (e.g., when channel 18 is at a given position with respect to tube 19); typically just before sleeve 26 becomes completely decoupled from channel 18. Engagement of member 127 inhibits proximal movement of channel 18 with respect to tube 19, thereby reducing a likelihood of (e.g., preventing) inadvertent release of sleeve 26. In order to release sleeve 26 (e.g., to decouple channel 18 from the sleeve), the operating physician must disengage member 127, such as by pushing the button, before continuing to withdraw channel 18 proximally. Typically, when engaged, member 127 also inhibits distal movement of channel 18 with respect to tube 19.

Handle portion 101 (comprising handles 22, 24, and 126 and anchor-release mechanism 28) has a length L1 of between 65 and 85 cm, e.g., 76 cm. Typically, as shown, a majority of the body portion of outer-catheter handle 22 is disposed at a non-zero angle with respect to a longitudinal axis 7 of the multiple components of system 10. The steering mechanism provided by handle 22 in order to steer the distal end portion of catheter 12 is disposed within the portion of handle 22 that is disposed at the non-zero angle with respect to axis 7. Handle 22 comprises an in-line tubular portion which is longitudinally disposed in-line along axis 7 and coaxially with respect to handles 24 and 126 and release mechanism 28. The in-line tubular portion is shaped so as to define a lumen for inserting guide catheter 14 therethrough and subsequently into the lumen of outer catheter 12. The in-line tubular portion has a length L24 of between 7 and 11 cm, e.g., 7 cm. Such spatial orientation of the majority of handle 22 at an angle with respect to axis 7 reduces an overall functional length of handle portion 101.

Typically, but not necessarily, a guidewire 2244 extends alongside sleeve 26 to facilitate positioning of sleeve 26 along the annulus.

For some applications, adjustment mechanism 40 is flexibly and/or articulatably coupled to sleeve 26 (e.g., by being coupled to the sleeve via a suture)

Reference is now made to FIGS. 3A-C, which are schematic illustrations of annuloplasty ring structure 222, comprising sleeve 26 and adjustment mechanism 40, in accordance with some applications of the invention. For some applications it is advantageous to (1) advance the structure to the mitral valve while mechanism 40 is disposed on the longitudinal axis of sleeve 26 (e.g., collinearly with the sleeve), so as to maintain a small cross-sectional diameter of the structure for transluminal delivery; and (2) to subsequently move mechanism 40 away from the longitudinal axis, e.g., so as to allow end wall 251 of the sleeve to be placed against the annulus, and/or so as to allow an anchor to be driven through the end wall of the sleeve. Structure 222 facilitates this technique by mechanism 40 being flexibly and/or articulatably coupled to sleeve 26.

Adjustment mechanism 40 of structure 222 is coupled to the lateral wall of sleeve 26 of structure 222, as shown in FIG. 3C. For delivery of structure 222, channel 18 is not disposed throughout the entire lumen of sleeve 26. Rather, a region 3224 (e.g., a distal region) of sleeve 26 is provided in which channel 18 is not disposed in the lumen of the sleeve, and mechanism 40 is pressed laterally into region 3224, such that the sleeve is compressed at region 3224, and mechanism 40 is disposed on the longitudinal axis of the sleeve (e.g., collinearly with the sleeve). Typically, region 3224 includes end wall 251 of sleeve 26. It is to be noted, however, that region 3224 may be provided at another position along the longitudinal axis of sleeve 26. Typically, mechanism 40 is fixedly coupled to the lateral wall of sleeve 26 at region 3224. In this state, structure 222 is disposed within catheter 14 for delivery.

Structure 222 is advanced out of catheter 14. Once at least adjustment mechanism 40 and/or structure/portion 222 is exposed from catheter 14, the adjustment mechanism moves (e.g., translates) away from the longitudinal axis of sleeve 26 (e.g., laterally), typically by channel 18 being moved distally such that it pushes laterally the portion of the lateral wall of the sleeve to which the adjustment mechanism is coupled (FIG. 3B). FIG. 3C shows channel 18 having been moved all the way to distal end 251 of sleeve 26, and mechanism 40 having been moved away from the longitudinal axis of the sleeve, so as to allow the distal end of the sleeve to be placed against the annulus, and/or so as to allow an anchor to be driven through the distal end wall of the sleeve.

Reference is made to FIGS. 4A-G, which are schematic illustrations of steps in the implantation of an annuloplasty ring structure to repair a mitral valve, in accordance with some applications of the invention. This procedure is one exemplary procedure that can be performed using system 10.

Annuloplasty ring structure 222 is used to repair a dilated valve annulus of an atrioventricular valve, such as mitral valve 230. For some applications, the annuloplasty ring is configured to be placed only partially around the valve annulus (e.g., to assume a C-shape), and, once anchored in place, to be contracted so as to circumferentially tighten the valve annulus. The annuloplasty ring comprises flexible sleeve 26 and a plurality of anchors 32. Anchor deployment manipulator 61 is advanced into a lumen of sleeve 26, and, from within the lumen, deploys the anchors through a wall of the sleeve and into cardiac tissue, thereby anchoring the sleeve around a portion of the valve annulus. For some applications, annuloplasty ring structure 222 is implemented using techniques described in U.S. application Ser. No. 12/437,103, filed May 7, 2009 which published as US 2010/0286767, and which issued as U.S. Pat. No. 8,715,342, and/or U.S. application Ser. No. 12/689,635, filed Jan. 19, 2010 which published as US 2010/0280604, and which issued as U.S. Pat. No. 8,545,553, both of which are assigned to the assignee of the present application and are incorporated herein by reference. As described hereinabove, annuloplasty ring structure 222 comprises adjustment mechanism 40. The adjustment mechanism comprises a rotatable structure, such as a spool, arranged such that rotation of the rotatable structure contracts the implant structure. The implant further comprises a longitudinal member, such as a wire, which is coupled to the adjustment mechanism. A rotation tool is provided for rotating the rotatable structure. The tool is configured to be guided along (e.g., over, alongside, or through) the longitudinal member, to engage the rotatable structure, and to rotate the rotatable structure in response to a rotational force applied to the tool.

The procedure typically begins by advancing a semi-rigid guidewire into a right atrium 220 of the patient. The procedure is typically performed with the aid of imaging, such as fluoroscopy, transesophageal echo, and/or echocardiography.

The guidewire provides a guide for the subsequent advancement of outer catheter 12 therealong and into the right atrium. Once a distal portion of catheter 12 has entered the right atrium, the guidewire is retracted from the patient's body. Catheter 12 typically comprises a 14-24 F sheath, although the size may be selected as appropriate for a given patient. Catheter 12 is advanced through vasculature into the right atrium using a suitable point of origin typically determined for a given patient. For example:

- catheter 12 may be introduced into the femoral vein of the patient, through an interior vena cava 223, into right atrium 220, and into a left atrium 224 transseptally, typically through the fossa ovalis;
- catheter 12 may be introduced into the basilic vein, through the subclavian vein to the superior vena cava, into right atrium 220, and into left atrium 224 transseptally, typically through the fossa ovalis; or
- catheter 12 may be introduced into the external jugular vein, through the subclavian vein to the superior vena cava, into right atrium 220, and into left atrium 224 transseptally, typically through the fossa ovalis.

For some applications of the present invention, catheter 12 is advanced through inferior vena cava 223 of the patient (as shown) and into right atrium 220 using a suitable point of origin typically determined for a given patient.

Catheter 12 is advanced distally until the sheath reaches the interatrial septum, and the guidewire is withdrawn.

A resilient needle and a dilator are advanced through catheter 12 and into the heart. In order to advance catheter 12 transseptally into left atrium 224, the dilator is advanced to the septum, and the needle is pushed from within the dilator and is allowed to puncture the septum to create an opening that facilitates passage of the dilator and subsequently catheter 12 therethrough and into left atrium 224. The dilator is passed through the hole in the septum created by the needle. Typically, the dilator is shaped to define a hollow shaft for passage along the needle, and the hollow shaft is shaped to define a tapered distal end. This tapered distal end is first advanced through the hole created by the needle. The hole is enlarged when the gradually increasing diameter of the distal end of the dilator is pushed through the hole in the septum. A distal-most end 102 of catheter 12 is tapered so as to facilitate passage of the distal portion of catheter 12 through the opening in the septum.

The advancement of catheter 12 through the septum and into the left atrium is followed by the extraction of the dilator and the needle from within catheter 12. Once the distal portion of catheter 12 is disposed within atrium 224, the steerable distal end portion of catheter 12 (which includes at least a portion of a bending section 1203) is steered in a first plane that is parallel to a plane of the annulus of mitral valve 230. Such steering moves the distal end portion of catheter 12 in a direction from the interatrial septum toward surrounding walls of the atrium, as indicated by the arrow in atrium 224. The steering of the distal portion of catheter 12 is performed via steering knob 210 of handle 22 in handle portion 101 (in FIG. 2).

As shown in FIG. 4A, annuloplasty ring structure 222 with channel 18 housing the anchor deployment manipulator 61 (not shown) therein is advanced through guide catheter 14, which is in turn, advanced through catheter 12 into left atrium 224. An exposed distal end portion 114 of catheter 14 extends beyond distal end 102 of catheter 12. Exposed distal end portion 114 is then (1) steered toward the annulus of valve 230 along a plane that is perpendicular with respect to the steering plane of catheter 12 and that is perpendicular with respect to valve 230, and is (2) bent, via a bending section 1403 toward valve 230. The steering of the distal portion of catheter 14 is performed via steering knob 214 of handle 24 in handle portion 101 (in FIG. 2).

FIG. 4A shows annuloplasty ring structure 222, comprising sleeve 26 and adjustment mechanism 40, having been advanced, via catheter 14, to a mitral valve 230. As shown in FIG. 4A, and as described hereinabove, during advancement of structure 222, adjustment mechanism 40 is disposed distal to (i.e., in front of) sleeve 26. In this way, adjustment mechanism 40 is disposed on the longitudinal axis of sleeve 26 (e.g., collinearly with the sleeve), so as to advantageously maintain a small cross-sectional diameter of the implant for transluminal delivery. Mechanism 40 is typically coupled to sleeve 26 via one or more connectors 27, such as sutures, which provide flexible and/or articulated coupling. A proximal end of connector 27 is disposed proximally to mechanism 40 (e.g., by being fixed to a portion of sleeve 26 proximal to mechanism 40 or by being accessible outside the body of the patient). A distal end of connector 27 is coupled (e.g., by being fixedly coupled by a knot or other mechanical coupling) to mechanism 40. Guide member 86, described hereinabove, typically extends distally from catheter 14, between end wall 251 of sleeve 26 and adjustment mechanism 40, and there is coupled to the adjustment mechanism. For some applications it is advantageous to (1) advance the structure to the mitral valve while mechanism 40 is disposed on the longitudinal axis of sleeve 26 (e.g., collinearly with the sleeve), so as to maintain a small cross-sectional diameter of the structure for transluminal delivery; and (2) to subsequently move mechanism 40 away from the longitudinal axis, e.g., so as to allow end wall 251 of the sleeve to be placed against the annulus, and/or so as to allow an anchor to be driven through the end wall of the sleeve. Connectors 27 facilitate this technique by making mechanism 40 flexibly and/or articulatably coupled to sleeve 26. For some applications, connectors 27 are tensioned or relaxed to move mechanism 40 with respect to sleeve 26 to reposition mechanism 40. For some applications, guide member 86 is tensioned or relaxed in order to reposition mechanism 40.

For some applications, mechanism 40 is coupled to sleeve 26 in a manner as described hereinabove with reference to FIGS. 1 and 3A-C.

Subsequent to exposure of at least adjustment mechanism 40 (and typically at least end wall 251 of sleeve 26) from catheter 14, the adjustment mechanism is moved away from end wall 251. Typically, this is achieved by guide member 86 being proximally such that mechanism 40 moves (e.g., translates, deflects, and/or rotates) away from the longitudinal axis of the sleeve, typically to become disposed laterally from sleeve 26. FIG. 4B shows mechanism 40 having translated to such a position. The movement of mechanism 40 away from end wall 251 of sleeve 26 advantageously allows end wall 251 of sleeve 26 to be placed against an atrial surface of an annulus 240, and a first one of anchors 32 to be driven through end wall 251 of the sleeve and into the annulus (FIG. 4C).

As shown in FIG. 4C, end wall 251 of sleeve 26 is positioned in a vicinity of a left fibrous trigone 242 of an annulus 240 of mitral valve 230. (It is noted that for clarity of illustration, distal end wall 251 of sleeve 26 is shown schematically in the cross-sectional view of the heart, although left trigone 242 is in reality not located in the shown cross-sectional plane, but rather out of the page closer to the viewer.) Alternatively, the distal end of sleeve 26 is positioned in a vicinity of a right fibrous trigone 244 of the mitral valve (configuration not shown). Further alternatively, the distal end of the sleeve is not positioned in the vicinity of either of the trigones, but is instead positioned elsewhere in a vicinity of the mitral valve, such as in a vicinity of the anterior or posterior commissure. Once positioned at the desired site near the selected trigone, deployment manipulator 61 deploys the first one of anchors 32 through the wall of sleeve 26 (by penetrating and passing through the wall of the sleeve in a direction in a direction parallel to a central longitudinal of deployment manipulator 61, or anchor driver 36, through the distal end of channel 18, and/or parallel to central longitudinal axis of tissue coupling element 60 of anchor 32) into cardiac tissue near the trigone. Following the deployment of anchor 32 in the cardiac tissue, deployment element 38 is decoupled from anchor 32.

Anchors 32 are typically deployed from a distal end of manipulator 61 while the distal end is positioned such that a central longitudinal axis through the distal end of manipulator 61 forms an angle with a surface of the cardiac tissue of between about 20 and 90 degrees, e.g., between 45 and 90 degrees, such as between about 75 and 90 degrees, such as about 90 degrees. Typically, anchors 32 are deployed from the distal end of manipulator 61 into the atrial surface of the cardiac tissue in a direction parallel to the central longitudinal axis through the distal end of manipulator 61. Such an angle is typically provided and/or maintained by channel 18 being more rigid than sleeve 26. Distal end 17 of channel 18 is typically brought close to the surface of the cardiac tissue (and the wall of sleeve 26 that is disposed against the surface of the cardiac tissue), such that little of each anchor 32 is exposed from channel 18 before penetrating the sleeve and the tissue. For example, distal end 17 of channel 18 may be placed (e.g., pushed) against the wall of the sleeve, sandwiching the sleeve against the cardiac tissue.

For some applications, such placement of distal end 17 of channel 18 against the cardiac tissue (via the wall of the sleeve), stabilizes the distal end during deployment and anchoring of each anchor 32, and thereby facilitates anchoring. For some applications, pushing of distal end 17 against the cardiac tissue (via the wall of the sleeve) temporarily deforms the cardiac tissue at the site of contact. This deformation may facilitate identification of the site of contact using imaging techniques (e.g., by identifying a deformation in the border between cardiac tissue and blood), and thereby may facilitate correct positioning of the anchor.

That is, the entire circular surface of distal end 17 of channel 18 is disposed in contact with the wall of sleeve 26 that is disposed against the surface of the cardiac tissue. As shown, distal end 17 is the lower-most circular tip of channel 18 and defines a distal opening of channel 18. In the configuration in which channel 18 is positioned in order to sandwich the portion of sleeve 26, the distal end 17 is disposed in parallel with a planar surface 255 of the tissue of annulus 240.

View-A provides an exploded view of components of system 10 isolated in relative spatial orientation. View-A shows (1) sleeve 26 and distal end wall 251, (2) channel 18 and distal end 17 thereof, and (3) tissue of annulus 240 at planar surface 255. Deployment manipulator 61 and anchor 32 are not shown in View-A for clarity of illustration. View-A shows the alignment of channel 18, specifically distal end 17 thereof, with respect to distal end wall 251 of sleeve 26, and tissue of annulus 240 at planar surface 255. That is, in such an alignment, distal end 17 is aligned substantially in parallel with respect to distal end wall 251 of sleeve 26, and tissue of annulus 240 at planar surface 255.

Also, for clarity in View-A, distal end 17 of channel 18 is distanced from end wall 251, which is distanced from the tissue of annulus 240. It is to be noted that this distancing is shown by way of illustration only, and that during the procedure of implanting anchor 32 into tissue and through wall 251, distal end 17 of channel contacts wall 251, which contacts tissue of annulus 240. That is, channel 18 is pushed against wall 251 such that distal end 17 of channel sandwiches wall 251 between distal end 17 and the tissue of annulus 240.

For some applications of the present invention, anchors 32 may be deployed from a lateral portion of manipulator 61.

As shown in the enlarged image of FIG. 4C, end wall 251 aligns against the tissue of annulus 240 in a manner in which a surface of end wall 251 is disposed in parallel with a planar surface 255 of the tissue of annulus 240. Additionally, distal end 17 of implant-decoupling channel 18 flattens end wall 251 against the tissue of annulus 240 in a manner in which channel 18 sandwiches end wall 251 between (1) distal end 17 of implant-decoupling channel, and (2) the portion of the tissue of annulus 240 at planar surface 255 into which a first one of anchors 32 is implanted. In such a manner, end wall 251 lies flat against the tissue of annulus 240 in parallel with planar surface 255, while at least a distal portion of tubular side wall 253 is disposed substantially perpendicularly with respect to the portion of the tissue of annulus 240 at planar surface 255 into which the first one of anchors 32 is implanted.

As shown, anchor 32 is implanted using channel 18 and manipulator 61 contained within sleeve 26 of annuloplasty structure 222 while at least a portion of annuloplasty structure 222 is contained within surrounding catheter 14.

Reference is now made to FIGS. 4C and 2. Following the deployment of the first tissue anchor, a distal portion of sleeve 26 is decoupled from a portion of implant-decoupling channel 18. In order to decouple the portion of sleeve 26 from outer surface of channel 18, (1) channel 18 is pulled proximally, while (2) reference-force tube 19 is maintained in place in a manner in which a distal end of tube 19 provides a reference force to sleeve 26 in order to facilitate retraction freeing of a successive portion of sleeve 26 from around channel 18. In order to decouple sleeve 26 from the outer surface of channel 18, (1) channel 18 is pulled proximally, while (2) reference-force tube 19 is maintained in place. An indicator 2120 on handle 126 provides an indication of how much channel 18 is withdrawn from within sleeve 26 (i.e., how much the delivery tool is decoupled from sleeve 26, and how much the sleeve has advanced off channel 18 and against tissue). A proximal end of channel 18 is coupled to a knob 94 (FIG. 2) which adjusts an axial position of channel 18 proximally and distally with respect to reference-force tube 19 and sleeve 26. As shown in FIG. 4D, deployment manipulator 61 is repositioned along annulus 240 to another site selected for deployment of a second one of anchors 32.

Reference is now made to FIGS. 2 and 4D. Such repositioning of manipulator 61 is accomplished by:

(1) the steering of the distal end portion of catheter 12 (e.g., by steering knob 210 of handle 22) in the first plane that is parallel with respect to annulus 240 of valve 230 to a desired spatial orientation and in a manner which bends bending section 1203 of catheter 12,

(2) the steering of the distal end portion of portion of catheter 14 (e.g., by steering knob 214 of handle 24) in the second plane that is perpendicular with respect to annulus 240 of valve 230 to a desired spatial orientation, and in a manner which bends bending section 1405 of catheter 14 (specifically bending section 1403),

(3) by axially moving catheter 14 with respect to catheter 12 via knob 216,

(4) by axially moving the stand supporting handles 22 and 24 to move both catheters 12 and 14,

(5) by moving tube 19 and sleeve 26 axially by sliding mount 93 along track 90 via knob 95, and/or

(6) by moving channel 18 relative to tube 19 by actuating knob 94.

As shown in the enlarged in-phantom image to the right, during repositioning of manipulator 61 (i.e., during flexing of the annuloplasty structure 222/sleeve 26 while distal end wall 251 is anchored), a generally-triangular shape is formed between: (1) guide member 86, (2) a distal end portion 257 of side wall 253 sleeve 26 (i.e., the portion of the sleeve that is proximal to end wall 251), and (3) channel 18 surrounded partially by catheter 14. It is to be noted that the illustrated triangle is shown in phantom to indicate the relative triangular orientation of the three components, and that the illustrated triangle is not a part of the apparatus shown.

Typically, the first tissue anchor is deployed most distally in the sleeve (generally at or within a few millimeters of the distal tip of the sleeve), and each subsequent anchor is deployed more proximally, such that the sleeve is gradually decoupled from channel 18 of deployment manipulator 61 in a distal direction during the anchoring procedure (i.e., channel 18 is withdrawn from within sleeve 26, and handle 126 is moved distally so as to retract the tool to make the successive proximal portion sleeve 26 ready for implantation of a subsequent anchor). The already-deployed first one of anchors 32 holds the anchored end of sleeve 26 in place, so that the sleeve is drawn from the site of the first tissue anchor towards the site of the second tissue anchor. As sleeve 26 is drawn and decoupled from channel 18, distal portion 257 of sleeve 26 (i.e., the portion of the sleeve that is proximal to end wall 251) is positioned in a vicinity of tissue of annulus 240.

Typically, as sleeve 26 is decoupled from channel 18, deployment manipulator 61 is moved generally laterally along planar surface 255 of the cardiac tissue, as shown in FIG. 4D in a manner which exposes distal portion 257 of sleeve 26 (i.e., the portion of the sleeve that is proximal to end wall 251) and flexes portion 257 to create a generally “U”-shaped portion (i.e., a portion having a concavity with respect to tissue of annulus 240 at planar surface 255). Forming portion 257 of sleeve 26 into the generally “U”-shaped portion (i.e., a portion having a concavity with respect to tissue of annulus 240 at planar surface 255) comprises creating a gap between portion 257 and the tissue of annulus 240 at planar surface 255, the gap having a longest distance D1 between 0.2 and 7.5 mm, e.g., 0.5 and 3 mm. Additionally, such forming of portion 257 is accomplished by flexing portion 257 while end wall 251 is anchored to the tissue of annulus 240. Typically, the gap is formed between (1) the tissue of annulus 240 at planar surface 255, and (2) a first part 258 of the lateral surface distal end portion of side wall 253 (i.e., at portion 257). First part 258 is disposed close to the tissue of annulus 240.

Typically, the “U”-shape differs from the natural shape of annulus 240, as it is distanced from the tissue.

Distal end portion 257 has a tubular, lateral surface. Portion 257 is formed into the generally “U”-shaped portion (i.e., a portion having a concavity with respect to tissue of annulus 240 at planar surface 255) such that first part 258 of the lateral surface of the distal end portion 257 of side wall 253 is formed into a concave surface with respect to the tissue of annulus 240. For some applications, when portion 257 is formed into the generally “U”-shaped portion (i.e., a portion having a concavity with respect to tissue of annulus 240 at planar surface 255), a shape is achieve in which: (1) first part 258, that is concave and disposed closer to the tissue of annulus 240, while (2) a second part 259 of the lateral surface of portion 257 of side wall 253 (i.e., opposite first part 258 and father away from the tissue of annulus 240) is more tensioned and less curved than first part 258. That is, first part 258 has (1) a greater degree of curvature than second part 259, (2) a smaller degree of tension than second part 259, and (3) a smaller radius of curvature than second part 259. Additionally, second part 259 has (1) a smaller degree of curvature than first part 258, (2) a greater degree of tension than first part 258, and (3) a larger radius of curvature than first part 259.

For some applications, part 258 is crimped or ruffled when portion 257 assumes the general “U”-shape.

For some applications, the shape of portion 257 is actively formed by flexing sleeve 26 by deployment manipulator 61. For other applications, the shape of portion 257 is passively assumed during the decoupling of portion 257 of sleeve 26 from channel 18, positioning of portion 257 in a vicinity of tissue of the annulus, and subsequently, anchoring side wall 253 to annulus 240 using the second tissue anchor.

FIG. 4D shows distal portion 257 of sleeve 26 (i.e., the portion of the sleeve that is proximal to end wall 251) having been decoupled from a portion of channel 18 by retracting channel 18 proximally. Depending on the tension applied between the first and second tissue anchor sites, the portion of sleeve 26 therebetween may remain tubular in shape, or may become flattened, which may help reduce any interference of the ring with blood flow.

FIG. 4E shows a second tissue anchor 32 (shown as a second tissue anchor 32b) being deployed through a portion of lateral side wall 253 of sleeve 26. As shown, the first one of anchors 32 deployed through end wall 251 is labeled as anchor 32a. Deployment manipulator 61 deploys the second tissue anchor by penetrating and passing through the wall of sleeve 26 into cardiac tissue at the second site.

As shown, anchor 32b is implanted using channel 18 and manipulator 61 contained within sleeve 26 of annuloplasty structure 222 while at least a portion of annuloplasty structure 222 is contained within surrounding catheter 14.

As described hereinabove, anchors 32a and 32b are each deployed from a distal end of manipulator 61 while the distal end is positioned such that a central longitudinal axis through the distal end of manipulator 61 forms an angle with a surface of the cardiac tissue of between about 20 and 90 degrees, e.g., between 45 and 90 degrees, such as between about 75 and 90 degrees, such as about 90 degrees. Typically, anchors 32 are deployed from the distal end of manipulator 61 into the atrial surface of the cardiac tissue in a direction parallel to the central longitudinal axis through the distal end of manipulator 61. Such an angle is typically provided and/or maintained by channel 18 being more rigid than sleeve 26. Distal end 17 of channel 18 is typically brought close to the surface of the cardiac tissue (and the wall of sleeve 26 that is disposed against the surface of the cardiac tissue), such that little of anchor 32b is exposed from channel 18 before penetrating the sleeve and the tissue. For example, distal end 17 of channel 18 may be placed (e.g., pushed) against the wall of the sleeve, sandwiching the sleeve against the cardiac tissue. Reference is made to FIGS. 4D-E. FIG. 4D shows channel 18 of deployment manipulator 61 positioned in alignment with a portion of tubular side wall 253 prior to implantation of the next, consecutive anchor 32 (i.e., 32b, as shown in FIG. 4E). 4D shows a View-B, which provides an exploded view of components of system 10 isolated in relative spatial orientation. View-B shows (1) sleeve 26 and a portion of tubular side wall 253, (2) channel 18 and distal end 17 thereof, and (3) tissue of annulus 240 at planar surface 255. Deployment manipulator 61 and anchor 32 are not shown in View-B for clarity of illustration. View-B shows the alignment of channel 18, specifically distal end 17 thereof, with respect to the portion of tubular side wall 253 of sleeve 26, and tissue of annulus 240 at planar surface 255. That is, in such an alignment, distal end 17 is aligned substantially in parallel with respect to the portion of tubular side wall 253 of sleeve 26, and tissue of annulus 240 at planar surface 255.

Also, for clarity in View-B, distal end 17 of channel 18 is distanced from the portion of tubular side wall 253, which is distanced from the tissue of annulus 240. It is to be noted that this distancing is shown by way of illustration only, and that during the procedure of implanting anchor 32 into tissue and through the portion of tubular side wall 253, distal end 17 of channel contacts the portion of tubular side wall 253, which contacts tissue of annulus 240. That is, channel 18 is pushed against the portion of tubular side wall 253 such that distal end 17 of channel sandwiches the portion of tubular side wall 253 between distal end 17 and the tissue of annulus 240.

As shown in the enlarged image of FIG. 4E, a portion of side wall 253 aligns against the tissue of annulus 240 in a manner in Which a surface of the portion of side wall 253 is disposed in parallel with planar surface 255 of the surface of the tissue of annulus 240. Additionally, distal end 17 of implant-decoupling channel 18 flattens the portion of side wall 253 against the tissue of annulus 240 in a manner in Which channel 18 sandwiches the portion of side wall 253 between (1) distal end 17 of implant-decoupling channel, and (2) the portion of the tissue of annulus 240 at planar surface 255 into which second tissue anchor 32b is implanted. In such a manner, the portion of side wall 253 lies flat against the tissue of annulus 240 in parallel with planar surface 255, while the remaining portion of tubular side wall 253 is disposed substantially perpendicularly with respect to the portion of the tissue of annulus 240 at planar surface 255 into which second tissue anchor 32b is implanted.

As shown in the right-most, above-view of FIG. 4E, first and second tissue anchors 32a and 32b extend in a substantially same direction and into a common, substantially planar surface 255 of a valve annulus. First and second anchors 32a and 32b extend in the substantially same direction despite that first tissue anchor 32a is deployed through end wall 251 transverse to side wall 253. That is, first and second anchors 32a and 32b extend in the substantially same direction while first tissue anchor 32a is deployed through end wall 251 transverse to side wall 253.

As shown in the bottom-left enlarged image, anchors 32a and 32b are deployed consecutively (i.e., in succession with no intervening anchor between anchors 32a and 32b) and extend in a substantially same direction. For example, anchors 32a and 32b are substantially parallel (e.g., parallel) with respect to each other. For some applications, anchors 32a and 32b are disposed with respect to each other at an angle of between 0 and 45 degrees, e.g., between 0 and 30 degrees, e.g., between 0 and 20 degrees. For some applications, first and second tissue anchors 32a and 32b, respectively, are deployed consecutively. That is, first and second tissue anchors 32a and 32b, respectively, are deployed in succession with no intervening anchor between anchors 32a and 32b, and a distance between anchors 32a and 32b is between 2.5 and 15 mm, e.g., between 2.5 and 9 mm, e.g., 8 mm.

Reference is now made to FIGS. 4C and 4E. It is to be noted that first and second tissue anchors 32a and 32b are deployed from within the lumen of channel 18 contained within the lumen of sleeve 26, while at least a proximal portion of sleeve 26 is surrounded by catheter 14, as shown.

Reference is again made to FIG. 4E. As shown, each of anchors 32a and 32b defines a respective central longitudinal axis 232a and 232b. Anchors 32a and 32b are substantially parallel (e.g., parallel) with respect to each other. For some applications, anchors 32a and 32b are implanted with respect to each other such that axes 232a and 232b are substantially parallel. For some applications, anchors 32a and 32b are implanted with respect to each other such that axes 232a and 232b are at angle of between 0 and 45 degrees, e.g., between 0 and 30 degrees, e.g., between 0 and 20 degrees.

For some applications, forming of portion 257 into the generally “U”-shaped portion (i.e., a portion having a concavity with respect to tissue of annulus 240 at planar surface 2551) comprises anchoring anchor 32b into tissue of annulus 240 at planar surface 255. Anchors 32a and 32b are implanted in tissue of annulus 240 along a common plane (i.e., planar surface 255) and extend in substantially the same direction (i.e., anchors 32a and 32b extend substantially parallel with respect to each other). First and second anchors 32a and 32b extend in the substantially same direction despite that first tissue anchor 32a is deployed through end wall 251 transverse to side wall 253. That is, first and second anchors 32a and 32b extend in the substantially same direction while first tissue anchor 32a is deployed through end wall 251 transverse to side wall 253.

For some applications, a maximum distance L10 between first tissue anchor 32a and a point of anchoring of second tissue anchor 32b is provided by the length of sleeve 26 that has been decoupled from the portion of channel 18 (e.g., by the distance that channel 18 has been retracted from sleeve 26, e.g., between 3 and 15 mm, e.g., 8 mm). That is, for some applications, second tissue anchor 32b may be placed anywhere within a circle having a radius that equals L10, centered on the first tissue anchor.

For some applications, a stiffening element 1926 is provided during the implantation of sleeve 26, and for some applications, the stiffening element facilitates positioning of portions of the sleeve and/or anchors 32, such as positioning of subsequent portions and/or anchors following positioning of previous portions and/or anchors. For example, and as shown in FIG. 4D, by resisting compression, stiffening element 1926 biases the positioning of the distal end of channel 18 (and thereby the position at which the second tissue anchor will be deployed) toward the perimeter of the circle described hereinabove that is centered on the first tissue anchor. That is, by resisting compression, stiffening element 1926 biases the second tissue anchor toward being disposed a distance L10 from the first tissue anchor. Due to, or independently from, this compression-resisting feature of stiffening element 1926, stiffening element 1926 typically maintains an overall length of sleeve 26, the length of the sleeve having typically been selected in response to measurement of the annulus on which it is to be implanted.

By resisting bending, stiffening element 1926 may further bias the positioning of the distal end of channel 18 (and thereby the position at which the second tissue anchor will be deployed) toward a particular sector of the circle. For some applications, by resisting compression and bending, stiffening element 1926 biases the positioning of the distal end of channel 18 (and thereby the position at which the second tissue anchor will be deployed) toward a particular sector of the perimeter of the circle, i.e., toward an arc 1928.

For some applications, by resisting bending, stiffening element 1926 biases sleeve 26 (and portions thereof) toward being straight, and thereby biases positioning of the distal end of channel 18 (and thereby the position at which the next anchor will be deployed) toward being on a line defined by at least the two preceding anchors (e.g., the two preceding anchors define a line segment of the line therebetween). FIG. 4E includes a schematic view illustrating first tissue anchor 32a, second tissue anchor 32b, and a corresponding portion of sleeve 26 having been anchored to annulus 240. A line 1927 is defined by the anchors 32a and 32b, stiffening element 1926 (not shown in this view) biasing a subsequent portion of sleeve 26 (and thereby subsequent anchors) to be disposed along line 1927. A desired position of a subsequent anchor is shown by cross 1930. This desired position is at the annulus, rather than closer to the center of the valve (e.g., the leaflets of the valve). Anatomical constraints and/or application of force by the operating physician oppose this biasing, such that the subsequent anchor is anchored at cross 1930. For such applications, the presence of stiffening element 1926 thereby facilitates placement of the subsequent anchor at annulus 240, as opposed to placement closer to the center of valve 230. It is to be noted that stiffening element 1926 biases structure 222 (e.g., sleeve 26 thereof) to assume a shape that is different to that of the native valve and/or native annulus. That is, stiffening element 1926 biases structure 222 (e.g., sleeve 26 thereof) to not conform to the shape of the native valve and/or native annulus.

For some applications, stiffening element 1926 helps maintain the shape of portion 257. That is, stiffening element 1926 helps maintain the general “U”-shape of portion 257 (i.e., the portion having a concavity with respect to tissue of annulus 240 at planar surface 255). For some applications, stiffening element 1926 helps bias portion 257 into the shape. Alternatively, for some applications, the shape of portion 257 as shown in FIG. 4E, is achieved without stiffening element 1926. For example, a distal end of stiffening element 1926 is disposed proximally to portion 257. For other applications, structure 222 does not comprise stiffening element 1926. For some applications, sleeve 26 at least portion 257 is resilient.

It is to be noted, however, that stiffening element 1926 is shown by way of illustration and not limitation, and that for some applications of the present invention structure 222 is provided without stiffening element 1926.

FIG. 4F shows the entire length of sleeve 26 having been anchored, via a plurality of anchors 32, to annulus 240, as described hereinabove. As shown, the plurality of remaining anchors 32 are implanted while maintaining distal portion 257 of sleeve 26 (i.e., the portion of the sleeve that is proximal to end wall 251) in a generally “U”-shaped portion (i.e., a portion having a concavity with respect to tissue of annulus 240 at planar surface 255).

The deployment manipulator (i.e., deployment manipulator 61 described herein but not shown in FIG. 4F) is repositioned along the annulus to additional sites, at which respective anchors are deployed, until the last anchor is deployed in a vicinity of right fibrous trigone 244 (or left fibrous trigone 242 if the anchoring began at the right trigone). Alternatively, the last anchor is not deployed in the vicinity of a trigone, but is instead deployed elsewhere in a vicinity of the mitral valve, such as in a vicinity of the anterior or posterior commissure. Then, system 10 is removed, leaving behind guide member 86.

FIG. 4G shows an adjustment tool 87 being threaded over and advanced along guide member 86. Adjustment tool 87 typically comprises a rotation tool, and is configured to actuate (e.g., rotate) adjustment mechanism 40, so as to contract contracting member 226, and thereby sleeve 26, as described hereinabove. Typically, adjustment mechanism 40 comprises a housing which houses a spool, i.e., a rotatable structure, to which a first end of contracting member 226 is coupled. Typically, the spool is configured to adjust a perimeter of annuloplasty ring structure 222 by adjusting a degree of tension of contracting member 226 that is coupled at a first portion of member 226 to the spool. The contracting member 226 extends along sleeve 26 and a second portion of contracting member 226 (i.e., a free end portion) is coupled to a portion of sleeve 26 such that upon rotation of the spool in a first rotational direction, the portion of sleeve 26 is pulled toward adjustment mechanism 40 in order to contract annuloplasty ring structure 222. It is to be noted that the contraction of structure 222 is reversible. That is, rotating the spool in a second rotational direction that opposes the first rotational direction used to contract the annuloplasty structure, unwinds a portion of contracting member 226 from around the spool. Unwinding the portion of contracting member 226 from around the spool thus feeds the portion of contracting member 226 back into a lumen of sleeve 26 of structure 222, thereby slackening the remaining portion of contracting member 226 that is disposed within the lumen sleeve 26. Responsively, the annuloplasty structure gradually relaxes and expands (i.e., with respect to its contracted state prior to the unwinding).

The spool typically comprises a locking mechanism that prevents rotation of the spool after contracting member 226 has been tightened. For example, locking techniques may be used that are described with reference to FIG. 4 of U.S. Pat. No. 8,241,351 to Cabiri.

Tool 87 and is used to rotate the spool of adjustment mechanism 4C) in order to tighten structure 222 by adjusting a degree of tension of contracting member 226 (not shown in FIG. 4G. Once the desired level of adjustment of structure 222 is achieved (e.g., by monitoring the extent of regurgitation of the valve under echocardiographic and/or fluoroscopic guidance), rotation tool 87 and guide member 86 are removed from the heart. For some applications, a distal portion of guide member 86 may be left within the heart of the patient and the proximal end may be accessible outside the body, e.g., using a port. For such applications, adjusting mechanism 40 may be accessed at a later stage following initial implantation and adjustment of ring structure 222.

As shown, sleeve 26 of ring structure 222 comprises a plurality of radiopaque markers 25, which are positioned along the sleeve at respective longitudinal sites to indicate anchor-designated target areas. The markers may provide an indication in a radiographic image (such as a fluoroscopy image) of how much of sleeve 26 has been deployed at any given point during an implantation procedure, in order to enable setting a desired distance between anchors 32 along the sleeve 26.

Alternatively, annuloplasty ring structure 222 is implanted by right or left thoracotomy, mutatis mutandis.

For some applications of the present invention, following implantation of sleeve 26 along the annulus, an excess portion of sleeve 26 may be present at the proximal portion of sleeve. In such applications, following removal of manipulator 61, a cutting tool (not shown) may be advanced within channel 18 and into the lumen of the excess portions of sleeve 26 (e.g., from within sleeve 26) in order to cut the sleeve proximal to the proximal-most-deployed anchor 32.

Reference is again made to FIGS. 4A-G. For anatomical reasons, a transluminal (e.g., transfemoral) approach to the mitral valve via transseptal puncture typically provides access more directly and/or easily to the region of the anterior commissure (e.g., including left fibrous trigone 242) than to the region of the posterior commissure (e.g., including right fibrous trigone 244). It may therefore be advantageous to position and anchor distal end wall 251 of sleeve 26 in the vicinity of the left fibrous trigone; the positioning of the first point of anchoring of structure 222 may be more difficult than the positioning of subsequent points of anchoring (e.g., due to guidance provided by sleeve 26 and/or stiffening element 1926; FIG. 4E). Due to this same reason of accessibility, it may also be advantageous to deliver adjustment tool 87 to the region of the anterior commissure (as shown in FIG. 4G).

System 10 (e.g., structure 222 thereof) is configured to facilitate exploitation of these two advantages: By adjustment mechanism 40 being disposed at a distal end of sleeve 26, and being movable away from the longitudinal axis of the sleeve, (1) the first tissue anchor may be driven through end wall 251 into the region of the anterior commissure, despite the adjustment mechanism having previously been obstructively positioned, and (2) the adjustment tool may be delivered to the region of the anterior commissure because the adjustment mechanism is disposed in that region.

Reference is made to FIG. 5, which is a schematic illustration of a state of a distal portion of system 10 within the heart of a subject, in accordance with some applications of the invention. As generally described hereinabove, (i) catheter 12 is steerable in a first plane, (ii) catheter 14 is steerable in a second plane that is typically perpendicular to the first plane, and (iii) distal portions of sleeve 26 are laid along the annulus of the native valve while proximal portions of the sleeve (and the distal end of manipulator 61, within the sleeve) are disposed at a nonzero angle with respect to the annulus. Thus, system 10 is configured to assume a multi-bend formation 2948 (e.g., handle portion 101 is configured to configure catheter 12, catheter 14, and structure 222 to assume the multi-bend formation) in which at least three domains 2950, and at least two bends 2952 separating the domains, are defined.

The formation includes (i) a first bend 2952a that separates a first domain 2950a of the formation from a second domain 2950b of the formation, and (ii) a second bend 2952b that separates the second domain from a third domain 2950c of the formation. Typically, the formation further includes a third bend 2952c that separates first domain 2950a from a fourth domain 2950d of the formation. First domain 2950a comprises at least (1) part of catheter 12 and (2) part of catheter 14 (i.e., at least a part of catheter 14 disposed within catheter 12), and typically further comprises at least part of sleeve 26 (i.e., at least part of sleeve 26 disposed within catheter 14). Second domain 2950b comprises at least part of catheter 14 (e.g., distal end portion 114 thereof), and at least part of sleeve 26 (e.g., the second domain comprises at least part of sleeve 26 disposed within a portion of catheter 14 that is exposed from catheter 12). Third domain 2950c comprises at least part of sleeve 26, and none of catheters 12 or 14 (i.e., the third domain comprises part of sleeve 26 that is disposed out of the distal end of catheter 14). In applications in which formation 2948 includes third bend 2952 and fourth domain 2950d, the fourth domain comprises at least (1) part of catheter 12 and (2) part of catheter 14 (i.e., at least a part of catheter 14 disposed within catheter 12), and may further comprise at least part of sleeve 26 (i.e., at least part of sleeve 26 disposed within catheter 14). Thus, domains 2950a and 2950d are typically of similar composition, but separated by third bend 2952c.

Thus, handle portion 101 may be considered to be configured:

to drive at least (i) part of catheter 12 and (ii) part of catheter 14 to define first domain 2950a,

to drive at least part of catheter 14 that is disposed outside of catheter 12 to define second domain 2950b,

to drive system 10 to define third domain 2950c from sleeve 26, and

typically, to drive at least (i) part of catheter 12 and (ii) part of catheter 14 to define fourth domain 2950d.

Reference is made to FIGS. 6A-C, which are schematic illustrations of a tissue anchor 2332 configured for anchoring sleeve 26 described hereinabove, in accordance with some applications of the present invention. Anchor 2332 has a coupling head 2310 configured to be coupled to a deployment element 2338, which has a locking mechanism 2128 disposed at a distal end thereof. Typically, deployment element 2338 (which comprises comprise deployment element 38, described herein) and a locking mechanism 2128. Locking mechanism 2128 is configured to selectively assume locked and unlocked states. When locking mechanism 2128 assumes the locked state, the locking mechanism prevents disengagement of rotating deployment element 2338 from the anchor which rotating deployment element 2338 currently engages. This locking allows deployment element 38 to proximally withdraw anchor 2332 if necessary, without coming disengaged therefrom. Disengagement is thus prevented even upon withdrawal of the rotating deployment element in the proximal direction. When the locking mechanism assumes the unlocked state, the locking mechanism does not prevent disengagement of the rotating deployment element from the anchor upon withdrawal of rotating deployment element 2338 in the proximal direction. The rotating deployment element thus can be disengaged and withdrawn from the anchor in a proximal direction. It is noted that even when the locking mechanism assumes the unlocked state, the rotating deployment element generally does not disengage from the anchor unless the rotating deployment element is withdrawn in the proximal direction.

For some applications, coupling head 2310 is alternatively or additionally configured to be coupled to, and/or used with, deployment manipulator 61, deployment element 38, and/or anchor driver 36 described hereinabove. Anchor 2332 provides a tissue coupling element 2312 (e.g., a helical tissue coupling element, as shown, or a screw). For some applications of the invention, anchor 32 described hereinabove, comprises anchor 2332 and/or anchors 32 and 2332 are interchangeable.

A proximal portion of coupling element 2312 comprises a vertical (and typically straight) proximal portion 2314 which is coupled to coupling head 2310 within 3 mm of a central longitudinal axis 2316 of tissue anchor 2332 (e.g., within 1 mm of axis 2316, such as on axis 2316). Proximal portion 2314 may alternatively comprise a proximal stem portion that couples coupling element 2312 to coupling head 2310. Vertical proximal portion 2314 typically has a length L36 of 0.2-0.7 mm, and is typically more than 1.3 times as great as (e.g., between 2 and 10 times as great as, such as between 2 and 4 times as great as) a thickness of the fabric of sleeve 26. During anchoring of sleeve 26 by anchor 2332 (e.g., as shown in FIG. 6B), such a configuration of the positioning of portion 2314 at the center of coupling head 2310 facilitates rotation of tissue anchor 2332 with respect to sleeve 26 in a manner that prevents twisting of sleeve 26 during rotation. That is, once coupling element 2312 has passed far enough through sleeve 26 such that portion 2314 traverses the wall of the sleeve (as shown in stage (iii) of FIG. 6B), portion 2314 rotates freely within the wall of the sleeve. (For some applications in which portion 2314 is coupled to coupling head 2310 within 3 mm of, but not on, axis 2316, flexibility of the fabric of sleeve 26 facilitates such free rotation, by distorting as portion 2314 “wiggles”.) Such a configuration allows anchor 2332 to be driven into the cardiac tissue, such that coupling head 2310 draws sleeve 26 closer to the cardiac tissue, without distorting (e.g., twisting, kinking, buckling, etc.) the sleeve (as shown by the transition from stage (iii) to stage (iv) of FIG. 6B). For some such applications, anchor 2332, coupling element 2312, and/or portion 2314 act as an integral washer and/or a screw with an integral washer, as is known in the hardware art.

Coupling head 2310 may be either male (e.g., a hex or square protrusion) or female (e.g., a straight slot, a hex opening, a Phillips opening, or a Robertson opening). The use of helical anchors, which are screwed into the cardiac tissue, generally minimizes the force that needs to be applied during deployment of the anchors into the cardiac tissue. Anchor driver 36 has a deployment element 38 that is either male (e.g., comprising a screwdriver head, having, such as a slot-head, an Allen-head, a Phillips-head, a Robertson-head, or a hex-head) or female (e.g., comprising a wrench head, having, for example, a square or hex opening), as appropriate for the driving interface provided by coupling head 2310 of anchor 2332 of FIGS. 6A-C.

Thus, anchor 2332, by way of illustration and not limitation, comprises a helical portion (i.e., tissue coupling element 2312) and a non-helically shaped portion (i.e., coupling head 2310 and vertical (and typically straight) proximal portion 2314).

Anchor 2332 has an anchor helix diameter L32 of between 0.2 and 0.3 cm, e.g., 0.25 cm. That is, the radius of the anchor helix from longitudinal axis 2316 is typically between 0.1 and 0.15 cm, e.g., 0.125 cm. Anchor 2332 has an anchor helix pitch L33 of between 0.1 and 0.2 cm, e.g., 0.12 cm. Anchor 2332 has an anchor helix length L34 of between 0.3 and 0.6 cm, such as 0.3 and 0.45 cm, e.g., 0.35 cm. Anchor 2332 has a helix wire thickness L35 of between 0.02 and 0.1 cm, e.g., 0.05 cm.

For some applications of the invention, torque-limiting apparatus 2300, coupled to anchor driver 36, prevents over-rotation of the anchor, penetration of tissue coupling element 2312 too deep into tissue, and/or damage to the tissue.

For some applications, a ratio between diameter L32 of the helix of anchor 2332 (cm) to torque (Ncm) is typically, but not necessarily 0.25/0.8, or 0.3125. For some applications, a ratio between pitch L33 of anchor 2332 (cm) to torque (Ncm) is typically, but not necessarily 0.12/0.8, or 0.15. For some applications, a ratio between length L34 of the helix of anchor 2332 (cm) to torque (Ncm) is typically, but not necessarily 0.35/0.8, or 0.4375. For some applications, a ratio between thickness L35 of the wire forming anchor 2332 (cm) to torque (Ncm) is typically, but not necessarily 0.05/0.8, or 0.0625.

Typically, but not necessarily, anchor 2332 comprises a biocompatible material such as stainless steel 316 LVM. For some applications, anchor 2332 comprises nitinol. For some applications, anchor 2332 is coated with a non-conductive material.

Reference is now made to FIG. 7, which is a schematic illustration of a step in the implantation of an annuloplasty ring structure to repair a mitral valve, in accordance with some applications of the invention. It is to be noted that the steps for implanting structure 222 are similar to those described in FIGS. 4A-G and 5 with the exception of portion 257 being implanted along the surface of the tissue of annulus 240, while minimizing or eliminating the gap (defined as having a distance D1) shown in FIGS. 5D-G and 5. As shown in FIG. 7, for some applications, due to the elasticity of the fabric, portion 257 of sleeve 26 is generally flush with respect to planar surface 255 of annulus 240 despite that first tissue anchor 32a is deployed through end wall 251 transverse to side wall 253 in substantially the same direction (as described hereinabove with reference to FIG. 4E). In such a manner a gap is minimized or eliminated between portion 257 and the tissue of annulus 240 at planar surface 255. That is, for some applications, part 258 of portion 257 is positioned adjacent, alongside, and touching the tissue of annulus 240.

Thus, in such an application of the present invention, structure forms a shape in which: (1) first part 258 of the lateral surface of portion 257 of side wall 253, is crimped or ruffled, while (2) second part 259 of the lateral surface of portion 257 of side wall 253 (i.e., opposite first part 258) is more tensioned and less curved than first part 258. That is, first part 258 has (1) a higher degree of curvature than second part 259, and (2) a smaller radius of curvature than second part 259. Additionally, second part 259 has (1) a smaller degree of curvature than first part 258, (2) a greater degree of tension than first part 258, and (3) a larger radius of curvature than first part 259.

It is to be noted that stiffening element 1926 is shown extending through portion 257 by way of illustration and not limitation. For example, for some applications, the shape of portion 257 as shown in FIG. 7, is achieved without stiffening element 1926. For example, a distal end of stiffening element 1926 is disposed proximally to portion 257. For other applications, structure 222 does not comprise stiffening element 1926. That is, without stiffening element 1926 in portion 257, portion 257 has a greater flexibility to achieve the ruffled and crimped configuration of part 258. For some applications, such flexibility is due to sleeve 26 comprising a fabric.

Reference is now made to FIGS. 4D-E and 7. As described hereinabove, the shape of portion 257 is achieved in situ actively by flexing sleeve 26 prior to deploying the second anchor 32b. For other applications, the shape of portion 257 is achieved passively in response to releasing portion 257 from channel 18 followed by anchoring wall 253 with second anchor 32b.

Reference is made to FIGS. 1-7. It is to be noted that following implantation of the annuloplasty structures described herein, the dimensions of the annuloplasty structures may be adjusted remotely and while the patient is not on a cardio-pulmonary bypass pump (i.e., with a beating heart), under fluoroscopy and/or echo guidance.

Although annuloplasty structure 222 has been described hereinabove as comprising a partial annuloplasty ring, in some embodiments of the present invention, the ring instead comprises a full annuloplasty ring.

It is to be further noted that system 10 and catheters 12 and 14 may be advanced using a (1) trans-septal procedure in which the system is advanced through vasculature of the patient at any suitable access location e.g., femoral vein), (2) a minimally-invasive transapical approach, (3) a minimally-invasive transatrial approach (e.g., an intercostal approach), or (4) a surgical, open-heart approach. Furthermore, for some applications, the systems described herein are not steerable and may comprise straight elements (e.g., in a surgical, open-heart procedure).

It is to be further noted that system 10 and catheters 12 and 14 for repairing a dilated annulus of the patient may be used to treat any cardiac valve of the patient, e.g., the aortic valve, the pulmonary valve, the mitral valve, and the tricuspid valve. It is to be still further noted that systems described herein for treatment of valves may be used to treat other annular muscles within the body of the patient. For example, the systems described herein may be used in order to treat a sphincter muscle within a stomach of the patient.

It is further noted that the scope of the present invention includes the use of system 10 and catheters 12 and 14 (or subcomponents thereof) and methods described hereinabove on any suitable tissue of the patient (e.g., stomach tissue, urinary tract, and prostate tissue).

In some embodiments of the present invention, system 10 is used to treat an atrioventricular valve other than the mitral valve, i.e., the tricuspid valve. In these embodiments, annuloplasty structure 222 and other components of system 10 described hereinabove as being placed in the left atrium are instead placed in the right atrium. Although annuloplasty structure 222 is described hereinabove as being placed in an atrium, for some application the ring is instead placed in either the left or right ventricle.

Additionally, the scope of the present invention includes embodiments described in the following applications, which are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:

- U.S. patent application Ser. No. 12/341,960 to Cabiri, entitled, “Adjustable partial annuloplasty ring and mechanism therefor,” filed on Dec. 22, 2008, which published as US Patent Application Publication 2010/0161047 and issued as U.S. Pat. No. 8,241,351;
- U.S. patent application Ser. No. 12/435,291 to Maisano et al., entitled, “Adjustable repair chords and spool mechanism therefor,” filed on May 4, 2009, which published as US Patent Application Publication 2010/0161041 and issued as U.S. Pat. No. 8,147,542;
- U.S. patent application Ser. No. 12/437,103 to Zipory et al., entitled, “Annuloplasty ring with intra-ring anchoring,” filed on May 7, 2009, which published as US Patent Application Publication 2010/0286767 and which issued as U.S. Pat. No. 8,715,342;
- U.S. patent application Ser. No. 12/548,991 to Maisano et al., entitled, “Implantation of repair chords in the heart,” filed on Aug. 27, 2009, which published as US Patent Application Publication 2010/0161042, and which issued as U.S. Pat. No. 8,808,368;
- PCT Patent Application PCT/IL2009/001209 to Cabiri et al., entitled, “Adjustable annuloplasty devices and mechanisms therefor,” filed on Dec. 22, 2009, which published as PCT Publication WO 10/073246;
- PCT Patent Application PCT/IL2010/000357 to Maisano et al., entitled, “Implantation of repair chords in the heart,” filed on May 4, 2010, which published as WO 10/128502;
- PCT Patent Application PCT/IL2010/000358 to Zipory et al., entitled, “Deployment techniques for annuloplasty ring and oven-wire rotation tool,” filed on May 4, 2010, which published as WO 10/128503; and/or
- PCT Patent Application PCT/IL2012/050451 to Sheps et al., entitled, “Controlled steering functionality for implant-delivery tool,” filed on Nov. 8, 2012, and which published as WO 13/069019.

It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims

1. A method for deploying a flexible annuloplasty structure at annulus tissue of a valve annulus, the method comprising: introducing the annuloplasty structure into a heart atrium, the annuloplasty structure having a sleeve with an elongated tubular side wall;anchoring a first section of the sleeve by deploying a first tissue anchor through the first section of the sleeve and into a first portion of the annulus tissue; andanchoring a second section of the sleeve by deploying a second tissue anchor through the second section of the sleeve and into a second portion of the annulus tissue, such that: a longitudinal portion of the tubular side wall is disposed between the first tissue anchor and the second tissue anchor, and has a first lateral part and a second lateral part opposite the first lateral part, the first lateral part being closer to the annulus than the second lateral part is to the annulus, andthe second lateral part of the longitudinal portion has a degree of tension that is larger than a degree of tension of the first lateral part of the longitudinal portion.
2. The method according to claim 1, wherein deploying the second tissue anchor comprises deploying the second tissue anchor such that the first tissue anchor and the second tissue anchor: (a) are deployed consecutively; and(b) extend in a substantially same direction and into a common, substantially planar surface of the valve annulus, the common, substantially planar surface including the first and second portions of the annulus tissue.
3. The method according to claim 1, wherein deploying the second tissue anchor comprises deploying the second tissue anchor substantially parallel with respect to the first tissue anchor.
4. The method according to claim 1, wherein deploying the second tissue anchor comprises deploying the second tissue anchor between 0 and 45 degrees with respect to the first tissue anchor.
5. The method according to claim 1, wherein deploying the first tissue anchor comprises deploying the first tissue anchor from a distal end of a deployment manipulator through the first section of the sleeve into the first portion of the annulus tissue, while the distal end of the deployment manipulator is positioned such that a central longitudinal axis through the distal end of the deployment manipulator forms an angle of between 20 and 90 degrees with the first section of the sleeve at a point at which the first tissue anchor penetrates the first section of the sleeve.
6. The method according to claim 1, wherein deploying the second tissue anchor comprises deploying the second tissue anchor from a distal end of a deployment manipulator through the second section of the sleeve into the second portion of the annulus tissue, while the distal end of the deployment manipulator is positioned such that a central longitudinal axis through the distal end of the deployment manipulator forms an angle of between 20 and 90 degrees with the second section of the sleeve at a point at which the second tissue anchor penetrates the second section of the sleeve.
7. The method according to claim 1, wherein deploying the first tissue anchor and deploying the second tissue anchor comprises deploying the first and second tissue anchors from within a lumen of the sleeve.
8. The method according to claim 1, wherein deploying the first tissue anchor and deploying the second tissue anchor comprises deploying the first and second tissue anchors from within a lumen of a channel disposed within a lumen of the sleeve while at least a proximal portion of the sleeve is surrounded by a catheter.
9. The method according to claim 1, wherein deploying the first tissue anchor comprises deploying the first tissue anchor through a channel disposed within a lumen of the sleeve, the channel having a distal end defining an opening through with the first tissue anchor passes, and wherein deploying the first tissue anchor comprises sandwiching the first section of the sleeve between the distal end of the channel and the first portion of the annulus tissue.
10. The method according to claim 9, wherein deploying the first tissue anchor comprises deploying the first tissue anchor into a planar surface of the valve annulus at the first portion of the annulus tissue, and wherein sandwiching comprises positioning the distal end of the channel in a manner in which the distal end of the channel is aligned substantially parallel to the planar surface.
11. The method according to claim 1, wherein deploying the second tissue anchor comprises deploying the second tissue anchor through a channel disposed within a lumen of the sleeve, the channel having a distal end defining an opening through with the second tissue anchor passes, and wherein deploying the second tissue anchor comprises sandwiching the second section of the sleeve between the distal end of the channel and the second portion of the annulus tissue.
12. The method according to claim 11, wherein deploying the second tissue anchor comprises deploying the second tissue anchor into a planar surface of the valve annulus at the first portion of the annulus tissue, and wherein sandwiching comprises positioning the distal end of the channel in a manner in which the distal end of the channel is aligned substantially parallel to the planar surface.
13. The method according to claim 1, further comprising, in conjunction with the anchoring the second section of the sleeve, forming the longitudinal portion of the tubular side wall into a shape having a concavity.
14. The method according to claim 13, wherein forming the longitudinal portion into the shape having the concavity comprises creating a gap between (1) the first lateral part, and (2) the annulus tissue, the gap having a longest distance between 0.2 and 7.5 mm.
15. A method for deploying a flexible annuloplasty structure at annulus tissue of a valve annulus, the method comprising: introducing the annuloplasty structure into a heart atrium, the annuloplasty structure having a sleeve with an elongated tubular side wall;anchoring a first section of the sleeve by deploying a first tissue anchor through the first section of the sleeve and into a first portion of the annulus tissue;while the first section of the sleeve is anchored, positioning alongside the valve annulus a longitudinal portion of the tubular side wall that is proximal to the first section of the sleeve in a manner in which the longitudinal portion of the tubular side wall that is proximal to the first section of the sleeve assumes a shape in which: a first lateral part of the longitudinal portion of the tubular side wall is positioned close to the annulus tissue,a second lateral part of the longitudinal portion of the tubular side wall is disposed opposite the first lateral part of the longitudinal portion of the tubular side wall and away from the annulus tissue, andthe second lateral part of the longitudinal portion of the tubular side wall has a degree of tension that is larger than a degree of tension of the first lateral part of the longitudinal portion of the tubular side wall; andanchoring the longitudinal portion of the tubular side wall to the annulus by deploying a second tissue anchor through a second section of the sleeve and into a second portion of the annulus tissue,wherein the first and second tissue anchors are disposed in a manner in which the longitudinal portion of the tubular side wall assumes the shape.
16. The method according to claim 15, wherein deploying the first tissue anchor and deploying the second tissue anchor comprises deploying the first and second tissue anchors from within a lumen of the sleeve.
17. The method according to claim 15, wherein positioning the longitudinal portion alongside the valve annulus comprises creating a gap between (1) the first lateral part, and (2) the annulus tissue, the gap having a longest distance between 0.2 and 7.5 mm.
18. The method according to claim 15, wherein deploying the first tissue anchor and deploying the second tissue anchor comprises deploying the first and second tissue anchors into a common, substantially planar surface of the valve annulus, the common, substantially planar surface including the first and second portions of the annulus tissue.
19. The method according to claim 18, wherein deploying the second tissue anchor comprises deploying the second tissue anchor substantially parallel with respect to the first tissue anchor.

CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation application of Ser. No. 14/141,228 to Zipory et al., entitled, “Implantation of flexible implant,” filed on Dec. 26, 2013, which published as US 2015/0182336, and which is assigned to the assignee of the present application and is incorporated herein by reference.

US Referenced Citations (830)

Number	Name	Date	Kind
3604488	Wishart	Sep 1971	A
3656185	Carpentier	Apr 1972	A
3840018	Heifetz	Oct 1974	A
3881366	Bradley et al.	May 1975	A
3898701	La Russa	Aug 1975	A
4042979	Angell	Aug 1977	A
4118805	Reimels	Oct 1978	A
4214349	Munch	Jul 1980	A
4261342	Aranguren Duo	Apr 1981	A
4290151	Massana	Sep 1981	A
4434828	Trincia	Mar 1984	A
4473928	Johnson	Oct 1984	A
4602911	Ahmadi et al.	Jul 1986	A
4625727	Leiboff	Dec 1986	A
4712549	Peters et al.	Dec 1987	A
4778468	Hunt et al.	Oct 1988	A
4917698	Carpenter et al.	Apr 1990	A
4961738	Mackin	Oct 1990	A
5061277	Carpentier et al.	Oct 1991	A
5064431	Gilbertson et al.	Nov 1991	A
5104407	Lam et al.	Apr 1992	A
5108420	Marks	Apr 1992	A
5201880	Wright	Apr 1993	A
5258008	Wilk	Nov 1993	A
5300034	Behnke	Apr 1994	A
5306296	Wright et al.	Apr 1994	A
5325845	Adair	Jul 1994	A
5346498	Greelis et al.	Sep 1994	A
5450860	O'Connor	Sep 1995	A
5474518	Farrer Velazquez	Dec 1995	A
5477856	Lundquist	Dec 1995	A
5593424	Northrup, III	Jan 1997	A
5601572	Middleman	Feb 1997	A
5626609	Zvenyatsky et al.	May 1997	A
5669919	Sanders et al.	Sep 1997	A
5674279	Wright et al.	Oct 1997	A
5683402	Cosgrove et al.	Nov 1997	A
5702397	Goble et al.	Dec 1997	A
5702398	Tarabishy	Dec 1997	A
5709695	Northrup, III	Jan 1998	A
5716370	Williamson et al.	Feb 1998	A
5716397	Myers	Feb 1998	A
5728116	Rosenman	Mar 1998	A
5730150	Peppel et al.	Mar 1998	A
5749371	Zadini et al.	May 1998	A
5810882	Bolduc	Sep 1998	A
5824066	Gross	Oct 1998	A
5830221	Stein et al.	Nov 1998	A
5843120	Israel et al.	Dec 1998	A
5855614	Stevens et al.	Jan 1999	A
5876373	Giba et al.	Mar 1999	A
5935098	Blaisdell	Aug 1999	A
5957953	DiPoto	Sep 1999	A
5961440	Schweich et al.	Oct 1999	A
5961539	Northrup, III et al.	Oct 1999	A
5984959	Robertson	Nov 1999	A
6042554	Rosenman	Mar 2000	A
6045497	Schweich et al.	Apr 2000	A
6050936	Schweich et al.	Apr 2000	A
6059715	Schweich et al.	May 2000	A
6074401	Gardiner et al.	Jun 2000	A
6074417	Peredo	Jun 2000	A
6102945	Campbell	Aug 2000	A
6106550	Magovern	Aug 2000	A
6110200	Hinnenkamp	Aug 2000	A
6143024	Campbell	Nov 2000	A
6159240	Sparer	Dec 2000	A
6165119	Schweich et al.	Dec 2000	A
6174332	Loch	Jan 2001	B1
6183411	Mortier	Feb 2001	B1
6187040	Wright	Feb 2001	B1
6315784	Djurovic	Feb 2001	B1
6217610	Carpentier	Apr 2001	B1
6231602	Carpentier	May 2001	B1
6251092	Qin et al.	Jun 2001	B1
6296656	Bodluc et al.	Oct 2001	B1
6319281	Patel	Nov 2001	B1
6332893	Mortier et al.	Dec 2001	B1
6355030	Aldrich et al.	Mar 2002	B1
6368348	Gabbay	Apr 2002	B1
6402780	Williamson, IV	Jun 2002	B2
6406420	McCarthy et al.	Jun 2002	B1
6406493	Tu	Jun 2002	B1
6419696	Ortiz et al.	Jul 2002	B1
6451054	Stevens	Sep 2002	B1
6461366	Seguin	Oct 2002	B1
6470892	Forsell	Oct 2002	B1
6503274	Howanec	Jan 2003	B1
6524338	Gundry	Feb 2003	B1
6533772	Sherts et al.	Mar 2003	B1
6537314	Langberg et al.	Mar 2003	B2
6547801	Dargent	Apr 2003	B1
6554845	Fleenor	Apr 2003	B1
6564805	Garrison et al.	May 2003	B2
6565603	Cox	May 2003	B2
6569198	Wilson et al.	May 2003	B1
6579297	Bicek et al.	Jun 2003	B2
6589160	Schweich et al.	Jul 2003	B2
6602288	Cosgrove	Aug 2003	B1
6602289	Colvin et al.	Aug 2003	B1
6613078	Barone	Sep 2003	B1
6613079	Wolinsky et al.	Sep 2003	B1
6619291	Hlavka et al.	Sep 2003	B2
6626899	Houser et al.	Sep 2003	B2
6626917	Craig	Sep 2003	B1
6626930	Allen et al.	Sep 2003	B1
6629534	St. Goar et al.	Oct 2003	B1
6629921	Schweich et al.	Oct 2003	B1
6651671	Donlon et al.	Nov 2003	B1
6652556	VanTasel	Nov 2003	B1
6682558	Tu et al.	Jan 2004	B2
6689125	Keith et al.	Feb 2004	B1
6689164	Seguin	Feb 2004	B1
6695866	Kuehn et al.	Feb 2004	B1
6702826	Liddicoat et al.	Mar 2004	B2
6702846	Mikus et al.	Mar 2004	B2
6706065	Langberg	Mar 2004	B2
6709385	Forsell	Mar 2004	B2
6709456	Langberg et al.	Mar 2004	B2
6711444	Koblish	Mar 2004	B2
6718985	Hlavka et al.	Apr 2004	B2
6719786	Ryan	Apr 2004	B2
6723038	Schroeder et al.	Apr 2004	B1
6726716	Marquez	Apr 2004	B2
6726717	Alfieri et al.	Apr 2004	B2
6730121	Ortiz et al.	May 2004	B2
6749630	McCarthy et al.	Jun 2004	B2
6752813	Goldfarb et al.	Jun 2004	B2
6764310	Ichihashi et al.	Jul 2004	B1
6764510	Vidlund et al.	Jul 2004	B2
6764810	Ma et al.	Jul 2004	B2
6770083	Seguin	Aug 2004	B2
6786924	Ryan et al.	Sep 2004	B2
6786925	Schoon	Sep 2004	B1
6790231	Liddicoat	Sep 2004	B2
6797001	Mathis	Sep 2004	B2
6797002	Spence et al.	Sep 2004	B2
6802319	Stevens et al.	Oct 2004	B2
6805710	Bolling et al.	Oct 2004	B2
6805711	Quijano et al.	Oct 2004	B2
6855126	Flinchbaugh	Feb 2005	B2
6858039	McCarthy	Feb 2005	B2
6884250	Monassevitch et al.	Apr 2005	B2
6893459	Macoviak	May 2005	B1
6908482	McCarthy et al.	Jun 2005	B2
6918917	Nguyen et al.	Jul 2005	B1
6926730	Nguyen et al.	Aug 2005	B1
6960217	Bolduc	Nov 2005	B2
6964684	Ortiz	Nov 2005	B2
6964686	Gordon	Nov 2005	B2
6976995	Mathis	Dec 2005	B2
6986775	Morales et al.	Jan 2006	B2
6989028	Lashinski et al.	Jan 2006	B2
6997951	Solem	Feb 2006	B2
7004176	Lau	Feb 2006	B2
7011669	Kimblad	Mar 2006	B2
7011682	Lashinski et al.	Mar 2006	B2
7037334	Hlavka et al.	May 2006	B1
7077850	Kortenbach	Jul 2006	B2
7077862	Vidlund	Jul 2006	B2
7087064	Hyde	Aug 2006	B1
7101395	Tremulis	Sep 2006	B2
7101396	Artof et al.	Sep 2006	B2
7112207	Allen et al.	Sep 2006	B2
7118595	Ryan	Oct 2006	B2
7125421	Tremulis et al.	Oct 2006	B2
7150737	Purdy et al.	Dec 2006	B2
7159593	McCarthy	Jan 2007	B2
7166127	Spence	Jan 2007	B2
7169187	Datta et al.	Jan 2007	B2
7172625	Shu et al.	Feb 2007	B2
7175660	Cartledge et al.	Feb 2007	B2
7186262	Saadat	Mar 2007	B2
7186264	Liddicoat	Mar 2007	B2
7189199	McCarthy et al.	Mar 2007	B2
7192443	Solem	Mar 2007	B2
7220277	Arru et al.	May 2007	B2
7226467	Lucatero et al.	Jun 2007	B2
7226477	Cox	Jun 2007	B2
7226647	Kasperchik et al.	Jun 2007	B2
7229452	Kayan	Jun 2007	B2
7238191	Bachmann	Jul 2007	B2
7288097	Seguin	Oct 2007	B2
7294148	McCarthy	Nov 2007	B2
7297150	Cartledge et al.	Nov 2007	B2
7311728	Solem et al.	Dec 2007	B2
7311729	Mathis	Dec 2007	B2
7314485	Mathis	Jan 2008	B2
7316710	Cheng et al.	Jan 2008	B1
7329279	Haug et al.	Feb 2008	B2
7329280	Bolling et al.	Feb 2008	B2
7335213	Hyde et al.	Feb 2008	B1
7361190	Shoulian	Apr 2008	B2
7364588	Mathis	Apr 2008	B2
7377941	Rhee	May 2008	B2
7390329	Westra et al.	Jun 2008	B2
7404824	Webler et al.	Jul 2008	B1
7431692	Zollinger et al.	Oct 2008	B2
7442207	Rafiee	Oct 2008	B2
7452376	Lim et al.	Nov 2008	B2
7455690	Cartledge et al.	Nov 2008	B2
7485142	Milo	Feb 2009	B2
7485143	Webler et al.	Feb 2009	B2
7500989	Solem et al.	Mar 2009	B2
7507252	Lashinski et al.	Mar 2009	B2
7510575	Spenser et al.	Mar 2009	B2
7510577	Moaddeb	Mar 2009	B2
7527647	Spence	May 2009	B2
7530995	Quijano	May 2009	B2
7549983	Roue et al.	Jun 2009	B2
7559936	Levine	Jul 2009	B2
7562660	Saadat	Jul 2009	B2
7563267	Goldfarb et al.	Jul 2009	B2
7563273	Goldfarb et al.	Jul 2009	B2
7569062	Kuehn	Aug 2009	B1
7588582	Starksen et al.	Sep 2009	B2
7591826	Alferness	Sep 2009	B2
7604646	Goldfarb et al.	Oct 2009	B2
7608091	Goldfarb et al.	Oct 2009	B2
7608103	McCarthy	Oct 2009	B2
7618449	Tremulis et al.	Nov 2009	B2
7625403	Krivoruchko	Dec 2009	B2
7632303	Stalker et al.	Dec 2009	B1
7635329	Goldfarb et al.	Dec 2009	B2
7635386	Gammie	Dec 2009	B1
7655015	Goldfarb et al.	Feb 2010	B2
7666204	Thornton	Feb 2010	B2
7682319	Martin	Mar 2010	B2
7682369	Seguin	Mar 2010	B2
7686822	Shayani	Mar 2010	B2
7699892	Rafiee	Apr 2010	B2
7704269	Goar	Apr 2010	B2
7704277	Zakay et al.	Apr 2010	B2
7722666	Lafontaine	May 2010	B2
7736388	Goldfarb et al.	Jun 2010	B2
7748389	Salahieh et al.	Jul 2010	B2
7753924	Starksen et al.	Jul 2010	B2
7758632	Hojeibane et al.	Jul 2010	B2
7780726	Seguin	Aug 2010	B2
7871368	Zollinger et al.	Jan 2011	B2
7871433	Lattouf	Jan 2011	B2
7883475	Dupont et al.	Feb 2011	B2
7883538	To et al.	Feb 2011	B2
7927370	Webler et al.	Apr 2011	B2
7927371	Navia	Apr 2011	B2
7942927	Kaye et al.	May 2011	B2
7947056	Griego et al.	May 2011	B2
7955377	Melsheimer	Jun 2011	B2
7988725	Gross	Aug 2011	B2
7992567	Hirotsuka	Aug 2011	B2
7993368	Gambale et al.	Aug 2011	B2
7993397	Lashinski	Aug 2011	B2
8012201	Lashinski et al.	Sep 2011	B2
8034103	Burriesci	Oct 2011	B2
8052592	Goldfarb et al.	Nov 2011	B2
8062355	Figulla et al.	Nov 2011	B2
8070804	Hyde	Dec 2011	B2
8070805	Vidlund	Dec 2011	B2
8075616	Solem	Dec 2011	B2
8100964	Spence	Jan 2012	B2
8123800	McCarthy	Feb 2012	B2
8123801	Milo	Feb 2012	B2
8323334	Deem	Feb 2012	B2
8142493	Spence et al.	Mar 2012	B2
8142495	Hasenkam	Mar 2012	B2
8142496	Berreklouw	Mar 2012	B2
8147542	Maisano et al.	Apr 2012	B2
8152844	Rao	Apr 2012	B2
8163013	Machold	Apr 2012	B2
8187299	Goldfarb et al.	May 2012	B2
8187324	Webler	May 2012	B2
8202315	Hlavka	Jun 2012	B2
8206439	Gomez-Duran	Jun 2012	B2
8216302	Wilson et al.	Jul 2012	B2
8226711	Mortier	Jul 2012	B2
8231671	Kim	Jul 2012	B2
8241351	Cabiri	Aug 2012	B2
8252050	Maisano et al.	Aug 2012	B2
8262725	Subramanian	Sep 2012	B2
8277502	Miller	Oct 2012	B2
8287584	Salahieh	Oct 2012	B2
8287591	Keidar	Oct 2012	B2
8303608	Goldfarb et al.	Nov 2012	B2
8328868	Paul	Dec 2012	B2
8333777	Schaller	Dec 2012	B2
8343173	Starksen et al.	Jan 2013	B2
8343174	Goldfarb	Jan 2013	B2
8343213	Salahieh et al.	Jan 2013	B2
8349002	Milo	Jan 2013	B2
8353956	Miller et al.	Jan 2013	B2
8357195	Kuehn	Jan 2013	B2
8382829	Call et al.	Feb 2013	B1
8388680	Starksen et al.	Mar 2013	B2
8393517	Milo	Mar 2013	B2
8430926	Kirson	Apr 2013	B2
8449599	Chau et al.	May 2013	B2
8454686	Alkhatib	Jun 2013	B2
8460370	Zakay et al.	Jun 2013	B2
8460371	Hlavka et al.	Jun 2013	B2
8475491	Milo	Jul 2013	B2
8480732	Subramanian	Jul 2013	B2
8500800	Maisano et al.	Aug 2013	B2
8518107	Tsukashima	Aug 2013	B2
8523881	Cabiri	Sep 2013	B2
8523940	Richardson	Sep 2013	B2
8545553	Zipory	Oct 2013	B2
8551161	Dolan	Oct 2013	B2
8585755	Chau et al.	Nov 2013	B2
8591576	Hasenkam	Nov 2013	B2
8608797	Gross	Dec 2013	B2
8628569	Benichou et al.	Jan 2014	B2
8628571	Hacohen	Jan 2014	B1
8641727	Starksen et al.	Feb 2014	B2
8652202	Alon et al.	Feb 2014	B2
8652203	Quadri et al.	Feb 2014	B2
8679174	Ottma et al.	Mar 2014	B2
8685086	Navia et al.	Apr 2014	B2
8690939	Miller et al.	Apr 2014	B2
8715342	Zipory	May 2014	B2
8728097	Sugimoto et al.	May 2014	B1
8728155	Montorfano et al.	May 2014	B2
8734467	Miller et al.	May 2014	B2
8740920	Goldfarb et al.	Jun 2014	B2
8747463	Fogarty et al.	Jun 2014	B2
8778021	Cartledge	Jul 2014	B2
8784481	Alkhatib et al.	Jul 2014	B2
8790367	Nguyen et al.	Jul 2014	B2
8790394	Miller et al.	Jul 2014	B2
8795298	Hernlund et al.	Aug 2014	B2
8795355	Alkhatib	Aug 2014	B2
8795356	Quadri et al.	Aug 2014	B2
8795357	Yohanan et al.	Aug 2014	B2
8808366	Braido et al.	Aug 2014	B2
8808368	Maisano et al.	Aug 2014	B2
8808371	Cartledge	Aug 2014	B2
8845717	Khairkhahan et al.	Sep 2014	B2
8845723	Spence et al.	Sep 2014	B2
8852261	White	Oct 2014	B2
8852272	Gross	Oct 2014	B2
8858623	Miller et al.	Oct 2014	B2
8864822	Spence et al.	Oct 2014	B2
8870948	Erzberger et al.	Oct 2014	B1
8870949	Rowe	Oct 2014	B2
8888843	Khairkhahan et al.	Nov 2014	B2
8894702	Quadri et al.	Nov 2014	B2
8911461	Traynor et al.	Dec 2014	B2
8911494	Hammer	Dec 2014	B2
8926695	Gross et al.	Jan 2015	B2
8926696	Cabiri et al.	Jan 2015	B2
8926697	Gross et al.	Jan 2015	B2
8932343	Alkhatib et al.	Jan 2015	B2
8932348	Solem et al.	Jan 2015	B2
8940042	Miller et al.	Jan 2015	B2
8940044	Hammer et al.	Jan 2015	B2
8945211	Sugimoto	Feb 2015	B2
8951285	Sugimoto et al.	Feb 2015	B2
8951286	Sugimoto et al.	Feb 2015	B2
8961595	Alkhatib	Feb 2015	B2
8961602	Kovach et al.	Feb 2015	B2
8979922	Jayasinghe et al.	Mar 2015	B2
9005273	Salahieh et al.	Apr 2015	B2
9011520	Miller et al.	Apr 2015	B2
9011530	Reich et al.	Apr 2015	B2
9017399	Gross	Apr 2015	B2
9023100	Quadri et al.	May 2015	B2
9034032	McLean et al.	May 2015	B2
9072603	Tuval et al.	Jul 2015	B2
9107749	Bobo et al.	Aug 2015	B2
9119719	Zipory	Sep 2015	B2
9125632	Loulmet et al.	Sep 2015	B2
9125742	Yoganathan et al.	Sep 2015	B2
9173646	Fabro	Nov 2015	B2
9180005	Lashinski et al.	Nov 2015	B1
9180007	Reich et al.	Nov 2015	B2
9192472	Gross et al.	Nov 2015	B2
9226825	Starksen et al.	Jan 2016	B2
9241702	Maisano et al.	Jan 2016	B2
9265608	Miller et al.	Feb 2016	B2
9326857	Cartledge et al.	May 2016	B2
9351830	Gross et al.	May 2016	B2
9414921	Miller et al.	Aug 2016	B2
9427316	Schweich et al.	Aug 2016	B2
9474606	Zipory et al.	Oct 2016	B2
9526613	Gross et al.	Dec 2016	B2
9561104	Miller et al.	Feb 2017	B2
9610162	Zipory	Apr 2017	B2
20010021874	Carpentier	Sep 2001	A1
20010044656	Williamson	Nov 2001	A1
20020022862	Grafton et al.	Feb 2002	A1
20020029080	Mortier	Mar 2002	A1
20020042621	Liddicoat	Apr 2002	A1
20020082525	Oslund et al.	Jun 2002	A1
20020087048	Brock et al.	Jul 2002	A1
20020103532	Langberg et al.	Aug 2002	A1
20020133180	Ryan et al.	Sep 2002	A1
20020151916	Muramatsu	Oct 2002	A1
20020151961	Lashinski	Oct 2002	A1
20020151970	Garrison	Oct 2002	A1
20020169358	Mortier et al.	Nov 2002	A1
20020173841	Ortiz et al.	Nov 2002	A1
20020177904	Huxel et al.	Nov 2002	A1
20020188301	Dallara et al.	Dec 2002	A1
20020198586	Inoue	Dec 2002	A1
20030018358	Saadat	Jan 2003	A1
20030050693	Quijano et al.	Mar 2003	A1
20030078465	Pai et al.	Apr 2003	A1
20030078653	Vesely	Apr 2003	A1
20030083742	Spence	May 2003	A1
20030100943	Bolduc	May 2003	A1
20030105519	Fasol et al.	Jun 2003	A1
20030114901	Loeb et al.	Jun 2003	A1
20030120340	Liska et al.	Jun 2003	A1
20030130731	Vidlund	Jul 2003	A1
20030167062	Gambale et al.	Sep 2003	A1
20030171760	Gambale	Sep 2003	A1
20030191528	Quijano et al.	Oct 2003	A1
20030199974	Lee et al.	Oct 2003	A1
20030204195	Keane	Oct 2003	A1
20030229350	Kay	Dec 2003	A1
20030229395	Cox	Dec 2003	A1
20030233142	Morales et al.	Dec 2003	A1
20040010287	Bonutti	Jan 2004	A1
20040019359	Worley et al.	Jan 2004	A1
20040019377	Taylor	Jan 2004	A1
20040024451	Johnson et al.	Feb 2004	A1
20040039442	St. Goar et al.	Feb 2004	A1
20040049207	Goldfarb et al.	Mar 2004	A1
20040059413	Argento	Mar 2004	A1
20040092962	Thornton et al.	May 2004	A1
20040122448	Levine	Jun 2004	A1
20040122514	Forgarty et al.	Jun 2004	A1
20040127982	Machold et al.	Jul 2004	A1
20040127983	Mortier et al.	Jul 2004	A1
20040133220	Lashinski et al.	Jul 2004	A1
20040133274	Webler et al.	Jul 2004	A1
20040133374	Kattan	Jul 2004	A1
20040138744	Lashinski et al.	Jul 2004	A1
20040138745	Macoviak et al.	Jul 2004	A1
20040148019	Vidlund et al.	Jul 2004	A1
20040148020	Vidlund et al.	Jul 2004	A1
20040148021	Cartledge et al.	Jul 2004	A1
20040153146	Lashinski et al.	Aug 2004	A1
20040172046	Hlavka	Sep 2004	A1
20040176788	Opolski	Sep 2004	A1
20040181287	Gellman	Sep 2004	A1
20040186566	Hindrichs	Sep 2004	A1
20040193191	Starksen et al.	Sep 2004	A1
20040236419	Milo	Nov 2004	A1
20040243227	Starsken et al.	Dec 2004	A1
20040249453	Cartledge	Dec 2004	A1
20040260317	Bloom et al.	Dec 2004	A1
20040260393	Rahdert et al.	Dec 2004	A1
20040260394	Douk et al.	Dec 2004	A1
20040267358	Reitan	Dec 2004	A1
20050004668	Aklog et al.	Jan 2005	A1
20050010287	Macoviak et al.	Jan 2005	A1
20050010787	Tarbouriech	Jan 2005	A1
20050016560	Voughlohn	Jan 2005	A1
20050055038	Kelleher et al.	Mar 2005	A1
20050055087	Starksen	Mar 2005	A1
20050060030	Lashinski et al.	Mar 2005	A1
20050065601	Lee et al.	Mar 2005	A1
20050070999	Spence	Mar 2005	A1
20050075727	Wheatley	Apr 2005	A1
20050085903	Lau	Apr 2005	A1
20050090827	Gedebou	Apr 2005	A1
20050096740	Langberg et al.	May 2005	A1
20050107812	Starksen et al.	May 2005	A1
20050107871	Realyvasquez et al.	May 2005	A1
20050119734	Spence	Jun 2005	A1
20050125002	Baran et al.	Jun 2005	A1
20050125011	Spence et al.	Jun 2005	A1
20050131533	Alfieri	Jun 2005	A1
20050137686	Salahieh et al.	Jun 2005	A1
20050137688	Salahieh et al.	Jun 2005	A1
20050137695	Salahieh	Jun 2005	A1
20050159728	Armour et al.	Jul 2005	A1
20050171601	Cosgrove et al.	Aug 2005	A1
20050177180	Kaganov	Aug 2005	A1
20050177228	Solem et al.	Aug 2005	A1
20050187613	Bolduc et al.	Aug 2005	A1
20050192596	Jugenheimer et al.	Sep 2005	A1
20050197696	Gomez Duran	Sep 2005	A1
20050203549	Realyvasquez	Sep 2005	A1
20050203606	VanCamp	Sep 2005	A1
20050216039	Lederman	Sep 2005	A1
20050216079	MaCoviak	Sep 2005	A1
20050222665	Aranyi	Oct 2005	A1
20050222678	Lashinski et al.	Oct 2005	A1
20050256532	Nayak et al.	Nov 2005	A1
20050267478	Corradi et al.	Dec 2005	A1
20050273138	To et al.	Dec 2005	A1
20050288776	Shaoulian et al.	Dec 2005	A1
20050288778	Shaoulian	Dec 2005	A1
20050288781	Moaddeb et al.	Dec 2005	A1
20060004442	Spenser et al.	Jan 2006	A1
20060004443	Liddicoat	Jan 2006	A1
20060020326	Bolduc et al.	Jan 2006	A9
20060020327	Lashinski et al.	Jan 2006	A1
20060020333	Lashinski et al.	Jan 2006	A1
20060020336	Liddicoat	Jan 2006	A1
20060025787	Morales et al.	Feb 2006	A1
20060025855	Lashinski et al.	Feb 2006	A1
20060025858	Alameddine	Feb 2006	A1
20060030885	Hyde	Feb 2006	A1
20060041319	Taylor et al.	Feb 2006	A1
20060052868	Mortier	Mar 2006	A1
20060058871	Zakay et al.	Mar 2006	A1
20060069429	Spence et al.	Mar 2006	A1
20060074486	Liddicoat	Apr 2006	A1
20060085012	Dolan	Apr 2006	A1
20060095009	Lampropoulos	May 2006	A1
20060106423	Weisel	May 2006	A1
20060116757	Lashinski et al.	Jun 2006	A1
20060122633	To	Jun 2006	A1
20060129166	Lavelle	Jun 2006	A1
20060149280	Harvine et al.	Jul 2006	A1
20060149368	Spence	Jul 2006	A1
20060161265	Levine et al.	Jul 2006	A1
20060184240	Jiminez	Aug 2006	A1
20060184242	Lichtenstein	Aug 2006	A1
20060195134	Crittenden	Aug 2006	A1
20060241622	Zergiebel	Oct 2006	A1
20060241656	Starksen et al.	Oct 2006	A1
20060241748	Lee et al.	Oct 2006	A1
20060247763	Slater	Nov 2006	A1
20060259135	Navia	Nov 2006	A1
20060271175	Woolfson	Nov 2006	A1
20060282161	Huyn et al.	Dec 2006	A1
20060287661	Bolduc	Dec 2006	A1
20060287716	Banbury et al.	Dec 2006	A1
20070001627	Lin et al.	Jan 2007	A1
20070016287	Cartledge et al.	Jan 2007	A1
20070016288	Gurskis	Jan 2007	A1
20070021781	Jervis	Jan 2007	A1
20070027533	Douk	Feb 2007	A1
20070027536	Mihaljevic et al.	Feb 2007	A1
20070038221	Fine	Feb 2007	A1
20070049942	Hindrichs et al.	Mar 2007	A1
20070049970	Belef et al.	Mar 2007	A1
20070051377	Douk et al.	Mar 2007	A1
20070055206	To et al.	Mar 2007	A1
20070061010	Hauser et al.	Mar 2007	A1
20070066863	Rafiee et al.	Mar 2007	A1
20070078297	Rafiee et al.	Apr 2007	A1
20070080188	Spence et al.	Apr 2007	A1
20070083168	Whiting et al.	Apr 2007	A1
20070100427	Perouse	May 2007	A1
20070106328	Wardle et al.	May 2007	A1
20070112359	Kimura	May 2007	A1
20070112422	Dehdashtian	May 2007	A1
20070112425	Schaller et al.	May 2007	A1
20070118151	Davidson	May 2007	A1
20070118154	Crabtree	May 2007	A1
20070118213	Loulmet	May 2007	A1
20070118215	Moaddeb	May 2007	A1
20070142907	Moaddeb	Jun 2007	A1
20070162111	Fukamachi et al.	Jul 2007	A1
20070198082	Kapadia et al.	Aug 2007	A1
20070213582	Zollinger et al.	Sep 2007	A1
20070219558	Deutsch	Sep 2007	A1
20070233239	Navia	Oct 2007	A1
20070239208	Crawford	Oct 2007	A1
20070244555	Rafiee	Oct 2007	A1
20070244556	Rafiee et al.	Oct 2007	A1
20070244557	Rafiee et al.	Oct 2007	A1
20070250160	Rafiee	Oct 2007	A1
20070255397	Ryan et al.	Nov 2007	A1
20070255400	Parravicini et al.	Nov 2007	A1
20070270755	Von Oepen et al.	Nov 2007	A1
20070270943	Solem et al.	Nov 2007	A1
20070276437	Call	Nov 2007	A1
20070282375	Hindrichs et al.	Dec 2007	A1
20070282429	Hauser et al.	Dec 2007	A1
20070295172	Swartz	Dec 2007	A1
20070299424	Cummings et al.	Dec 2007	A1
20080004697	Lichtenstein et al.	Jan 2008	A1
20080027483	Cartledge	Jan 2008	A1
20080027555	Hawkins	Jan 2008	A1
20080035160	Wodson et al.	Feb 2008	A1
20080039935	Buch	Feb 2008	A1
20080051703	Thornton et al.	Feb 2008	A1
20080058595	Snoke et al.	Mar 2008	A1
20080065011	Marchand et al.	Mar 2008	A1
20080065204	Mackoviak	Mar 2008	A1
20080071366	Tuval	Mar 2008	A1
20080086138	Stone et al.	Apr 2008	A1
20080086203	Roberts	Apr 2008	A1
20080091257	Andreas et al.	Apr 2008	A1
20080097523	Bolduc et al.	Apr 2008	A1
20080125861	Webler et al.	May 2008	A1
20080140116	Bonutti	Jun 2008	A1
20080167714	St. Goar	Jul 2008	A1
20080177382	Hyde et al.	Jul 2008	A1
20080195126	Solem	Aug 2008	A1
20080195200	Vidlund	Aug 2008	A1
20080208265	Frazier et al.	Aug 2008	A1
20080221672	Lamphere	Sep 2008	A1
20080243245	Thambar	Oct 2008	A1
20080262480	Stahler et al.	Oct 2008	A1
20080262609	Gross	Oct 2008	A1
20080275300	Rothe	Nov 2008	A1
20080275469	Fanton	Nov 2008	A1
20080275551	Alfieri	Nov 2008	A1
20080281411	Berreklouw	Nov 2008	A1
20080288044	Osborne	Nov 2008	A1
20080288062	Andrieu et al.	Nov 2008	A1
20080300537	Bowman	Dec 2008	A1
20080300629	Surti	Dec 2008	A1
20090028670	Garcia et al.	Jan 2009	A1
20090043153	Zollinger et al.	Feb 2009	A1
20090043381	Macoviak	Feb 2009	A1
20090054969	Salahieh	Feb 2009	A1
20090062866	Jackson	Mar 2009	A1
20090076586	Hauser	Mar 2009	A1
20090076600	Quinn	Mar 2009	A1
20090088837	Gillinov	Apr 2009	A1
20090093877	Keidar et al.	Apr 2009	A1
20090099650	Bolduc	Apr 2009	A1
20090105816	Olsen	Apr 2009	A1
20090125102	Cartledge	May 2009	A1
20090149872	Gross et al.	Jun 2009	A1
20090177274	Scorsin	Jun 2009	A1
20090171439	Nissl	Jul 2009	A1
20090177266	Powell et al.	Jul 2009	A1
20090177277	Milo	Jul 2009	A1
20090222083	Nguyen et al.	Sep 2009	A1
20090248148	Shaolian	Oct 2009	A1
20090254103	Deustch	Oct 2009	A1
20090259307	Gross et al.	Oct 2009	A1
20090264994	Saadat	Oct 2009	A1
20090264995	Subramanian	Oct 2009	A1
20090287231	Brooks et al.	Nov 2009	A1
20090287304	Dahlgren	Nov 2009	A1
20090299409	Coe	Dec 2009	A1
20090326648	Machold et al.	Dec 2009	A1
20100001038	Levin	Jan 2010	A1
20100010538	Juravic	Jan 2010	A1
20100023117	Yoganathan	Jan 2010	A1
20100023118	Medlock et al.	Jan 2010	A1
20100030014	Ferrazzi	Feb 2010	A1
20100030328	Seguin	Feb 2010	A1
20100042147	Janovsky et al.	Feb 2010	A1
20100049313	Alon et al.	Feb 2010	A1
20100063542	Van der Burg	Mar 2010	A1
20100063550	Felix	Mar 2010	A1
20100063586	Hasenkam	Mar 2010	A1
20100076499	McNamara et al.	Mar 2010	A1
20100094248	Nguyen et al.	Apr 2010	A1
20100114180	Rock	May 2010	A1
20100121349	Meier	May 2010	A1
20100121435	Subramanian et al.	May 2010	A1
20100121437	Subramanian et al.	May 2010	A1
20100130992	Machold et al.	May 2010	A1
20100152845	Bloom	Jun 2010	A1
20100161041	Maisano et al.	Jun 2010	A1
20100161042	Maisano et al.	Jun 2010	A1
20100161043	Maisano et al.	Jun 2010	A1
20100161047	Cabiri	Jun 2010	A1
20100168845	Wright	Jul 2010	A1
20100174358	Rabkin et al.	Jul 2010	A1
20100179574	Longoria	Jul 2010	A1
20100198347	Zakay et al.	Aug 2010	A1
20100211166	Miller et al.	Aug 2010	A1
20100217184	Koblish et al.	Aug 2010	A1
20100217382	Chau	Aug 2010	A1
20100234935	Bashiri et al.	Sep 2010	A1
20100249915	Zhang	Sep 2010	A1
20100249920	Bolling	Sep 2010	A1
20100262232	Annest	Oct 2010	A1
20100262233	He	Oct 2010	A1
20100280603	Maisano et al.	Nov 2010	A1
20100280604	Zipory	Nov 2010	A1
20100280605	Hammer	Nov 2010	A1
20100286628	Gross	Nov 2010	A1
20100286767	Zipory	Nov 2010	A1
20100305475	Hinchliffe et al.	Dec 2010	A1
20100324598	Anderson	Dec 2010	A1
20110004210	Johnson	Jan 2011	A1
20110004298	Lee	Jan 2011	A1
20110011917	Loulmet	Jan 2011	A1
20110026208	Otsuro et al.	Feb 2011	A1
20110029066	Gilad	Feb 2011	A1
20110035000	Nieminen et al.	Feb 2011	A1
20110066231	Cartledge	Mar 2011	A1
20110067770	Pederson et al.	Mar 2011	A1
20110071626	Wright et al.	Mar 2011	A1
20110082538	Dahlgren et al.	Apr 2011	A1
20110087146	Ryan et al.	Apr 2011	A1
20110093002	Rucker et al.	Apr 2011	A1
20110106245	Miller et al.	May 2011	A1
20110106247	Miller	May 2011	A1
20110118832	Punjabi	May 2011	A1
20110137410	Hacohen	Jun 2011	A1
20110144703	Krause	Jun 2011	A1
20110166649	Gross	Jul 2011	A1
20110184510	Maisano et al.	Jul 2011	A1
20110190879	Bobo et al.	Aug 2011	A1
20110202130	Cartledge	Aug 2011	A1
20110208283	Rust	Aug 2011	A1
20110224785	Hacohen	Sep 2011	A1
20110230941	Markus	Sep 2011	A1
20110230961	Langer	Sep 2011	A1
20110238088	Bolduc et al.	Sep 2011	A1
20110257433	Walker	Oct 2011	A1
20110257633	Cartledge	Oct 2011	A1
20110257728	Kuehn	Oct 2011	A1
20110264208	Duffy	Oct 2011	A1
20110276062	Bolduc	Nov 2011	A1
20110282361	Miller et al.	Nov 2011	A1
20110288435	Christy et al.	Nov 2011	A1
20110288635	Miller	Nov 2011	A1
20110301498	Maenhout et al.	Dec 2011	A1
20110301698	Miller et al.	Dec 2011	A1
20120022557	Cabiri	Jan 2012	A1
20120022639	Hacohen et al.	Jan 2012	A1
20120022640	Gross et al.	Jan 2012	A1
20120022644	Reich	Jan 2012	A1
20120035712	Maisano et al.	Feb 2012	A1
20120078355	Zipory	Mar 2012	A1
20120078359	Li et al.	Mar 2012	A1
20120089022	House et al.	Apr 2012	A1
20120095552	Spence	Apr 2012	A1
20120109155	Robinson et al.	May 2012	A1
20120123531	Tsukashima	May 2012	A1
20120136436	Cabiri	May 2012	A1
20120143323	Hasenkam	Jun 2012	A1
20120150290	Gabbay	Jun 2012	A1
20120158021	Morrill	Jun 2012	A1
20120179086	Shank	Jul 2012	A1
20120191182	Hauser et al.	Jul 2012	A1
20120197388	Khairkhahan et al.	Aug 2012	A1
20120226349	Tuval et al.	Sep 2012	A1
20120239142	Liu et al.	Sep 2012	A1
20120245604	Tegzes	Sep 2012	A1
20120271198	Whittaker et al.	Oct 2012	A1
20120283757	Miller	Nov 2012	A1
20120296349	Smith et al.	Nov 2012	A1
20120296417	Hill	Nov 2012	A1
20120296419	Richardson	Nov 2012	A1
20120310330	Buchbinder et al.	Dec 2012	A1
20120323313	Seguin	Dec 2012	A1
20120330410	Hammer	Dec 2012	A1
20120330411	Gross	Dec 2012	A1
20130023758	Fabro	Jan 2013	A1
20130030522	Rowe et al.	Jan 2013	A1
20130035759	Gross et al.	Feb 2013	A1
20130046373	Cartledge et al.	Feb 2013	A1
20130079873	Migliazza	Mar 2013	A1
20130297013	Klima et al.	Mar 2013	A1
20130085529	Housman	Apr 2013	A1
20130090724	Subramanian	Apr 2013	A1
20130096672	Reich	Apr 2013	A1
20130096673	Hill	Apr 2013	A1
20130116776	Gross et al.	May 2013	A1
20130116780	Miller	May 2013	A1
20130123910	Cartledge	May 2013	A1
20130131791	Hlavka et al.	May 2013	A1
20130131792	Miller	May 2013	A1
20130166017	Cartledge et al.	Jun 2013	A1
20130172992	Gross et al.	Jul 2013	A1
20130190863	Call et al.	Jul 2013	A1
20130190866	Zipory	Jul 2013	A1
20130197632	Kovach	Aug 2013	A1
20130204361	Adams	Aug 2013	A1
20130226289	Shaolian	Aug 2013	A1
20130226290	Yellin et al.	Aug 2013	A1
20130268069	Zakai et al.	Oct 2013	A1
20130289718	Tsukashima et al.	Oct 2013	A1
20130304093	Serina et al.	Nov 2013	A1
20130325118	Cartledge	Dec 2013	A1
20140018914	Zipory et al.	Jan 2014	A1
20140088368	Park	Mar 2014	A1
20140094826	Sutherland et al.	Apr 2014	A1
20140094903	Miller et al.	Apr 2014	A1
20140094906	Spence et al.	Apr 2014	A1
20140135799	Henderson	May 2014	A1
20140142619	Serina et al.	May 2014	A1
20140142695	Gross et al.	May 2014	A1
20140148849	Serina et al.	May 2014	A1
20140148898	Gross et al.	May 2014	A1
20140155783	Starksen et al.	Jun 2014	A1
20140163670	Alon et al.	Jun 2014	A1
20140163690	White	Jun 2014	A1
20140188108	Goodine et al.	Jul 2014	A1
20140188140	Meier et al.	Jul 2014	A1
20140188215	Hlavka et al.	Jul 2014	A1
20140194976	Starksen et al.	Jul 2014	A1
20140207231	Hacohen et al.	Jul 2014	A1
20140222137	Miller et al.	Aug 2014	A1
20140243859	Robinson	Aug 2014	A1
20140243894	Groothuis et al.	Aug 2014	A1
20140243963	Sheps et al.	Aug 2014	A1
20140257475	Gross et al.	Sep 2014	A1
20140275757	Goodwin et al.	Sep 2014	A1
20140276648	Hammer et al.	Sep 2014	A1
20140296962	Cartledge et al.	Oct 2014	A1
20140303649	Nguyen et al.	Oct 2014	A1
20140303720	Sugimoto et al.	Oct 2014	A1
20140309661	Sheps et al.	Oct 2014	A1
20140309730	Alon	Oct 2014	A1
20140324164	Gross et al.	Oct 2014	A1
20140343668	Zipory	Nov 2014	A1
20140379006	Sutherland et al.	Dec 2014	A1
20150012087	Miller et al.	Jan 2015	A1
20150018940	Quill et al.	Jan 2015	A1
20150051697	Spence et al.	Feb 2015	A1
20150081014	Gross et al.	Mar 2015	A1
20150105855	Cabiri et al.	Apr 2015	A1
20150112432	Reich et al.	Apr 2015	A1
20150127097	Neumann et al.	May 2015	A1
20150182336	Zipory et al.	Jul 2015	A1
20150230924	Miller	Aug 2015	A1
20150272586	Herman et al.	Oct 2015	A1
20150272734	Sheps	Oct 2015	A1
20150282931	Brunnett et al.	Oct 2015	A1
20150297212	Reich et al.	Oct 2015	A1
20150351906	Hammer	Dec 2015	A1
20160008132	Cabiri et al.	Jan 2016	A1
20160058557	Reich et al.	Mar 2016	A1
20160113767	Miller et al.	Apr 2016	A1
20160158008	Miller et al.	Jun 2016	A1
20160242762	Gilmore et al.	Aug 2016	A1
20160262755	Zipory et al.	Sep 2016	A1
20160302917	Schewel	Oct 2016	A1
20160317302	Madjarov et al.	Nov 2016	A1
20160324633	Gross et al.	Nov 2016	A1
20160361168	Gross et al.	Dec 2016	A1
20160361169	Gross et al.	Dec 2016	A1
20170000609	Gross et al.	Jan 2017	A1

Foreign Referenced Citations (107)

Number	Date	Country
2671966	Jun 2008	CA
101653365	Feb 2010	CN
0611561	Aug 1994	EP
0614342	Sep 1994	EP
1006905	Jun 2000	EP
0954257	Aug 2000	EP
1258437	Nov 2002	EP
0871417	Oct 2003	EP
1266641	Oct 2004	EP
1034753	Feb 2005	EP
1258232	Jan 2006	EP
1990014	Nov 2008	EP
1562522	Dec 2008	EP
1420723	Jan 2009	EP
1903991	Sep 2009	EP
1418865	Oct 2009	EP
2119399	Nov 2009	EP
1531762	Apr 2010	EP
1450733	Feb 2011	EP
1861045	Mar 2015	EP
1465555	May 2015	EP
223448	Dec 2012	IL
9205093	Apr 1992	WO
9310714	Jun 1993	WO
1993015690	Aug 1993	WO
9639963	Dec 1996	WO
9640344	Dec 1996	WO
9701369	Jan 1997	WO
9846149	Oct 1998	WO
1999030647	Jun 1999	WO
99033414	Jul 1999	WO
99063907	Dec 1999	WO
99063910	Dec 1999	WO
2000009048	Feb 2000	WO
0022981	Apr 2000	WO
0126586	Apr 2001	WO
0156457	Aug 2001	WO
2001087191	Nov 2001	WO
02085250	Oct 2002	WO
02085251	Oct 2002	WO
02085252	Oct 2002	WO
03028558	Apr 2003	WO
03047467	Jun 2003	WO
2003049647	Jun 2003	WO
2003105667	Dec 2003	WO
2004012583	Feb 2004	WO
2004019816	Mar 2004	WO
2004019826	Mar 2004	WO
04103434	Dec 2004	WO
05021063	Mar 2005	WO
05046488	May 2005	WO
2005062931	Jul 2005	WO
06012013	Feb 2006	WO
06012038	Feb 2006	WO
06086434	Aug 2006	WO
06097931	Sep 2006	WO
06105084	Oct 2006	WO
06116558	Nov 2006	WO
07011799	Jan 2007	WO
2007080595	Jul 2007	WO
07121314	Oct 2007	WO
07136783	Nov 2007	WO
07136981	Nov 2007	WO
2008014144	Jan 2008	WO
2008031103	Mar 2008	WO
08068756	Jun 2008	WO
2009160631	Oct 2009	WO
10004546	Jan 2010	WO
2010000454	Jan 2010	WO
2010006905	Jan 2010	WO
2010044851	Apr 2010	WO
2010065274	Jun 2010	WO
10073246	Jul 2010	WO
2010085649	Jul 2010	WO
2010128502	Nov 2010	WO
2010128503	Nov 2010	WO
2010150178	Dec 2010	WO
2011051942	May 2011	WO
11067770	Jun 2011	WO
2011089401	Jul 2011	WO
2011089601	Jul 2011	WO
2011111047	Sep 2011	WO
2011148374	Dec 2011	WO
2011154942	Dec 2011	WO
2012011108	Jan 2012	WO
2012014201	Feb 2012	WO
2012068541	May 2012	WO
2012106346	Aug 2012	WO
2012176195	Dec 2012	WO
2013021374	Feb 2013	WO
2013021375	Feb 2013	WO
2013069019	May 2013	WO
2013078497	Jun 2013	WO
2013088327	Jun 2013	WO
2014064694	May 2014	WO
2014064695	May 2014	WO
2014064964	May 2014	WO
2014076696	May 2014	WO
2014087402	Jun 2014	WO
2014108903	Jul 2014	WO
2014115149	Jul 2014	WO
2014195786	Dec 2014	WO
2015059699	Apr 2015	WO
2015193728	Dec 2015	WO
2016059639	Apr 2016	WO
2016087934	Jun 2016	WO
2016174669	Nov 2016	WO

Non-Patent Literature Citations (301)

Entry
O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006).
Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003).
Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994).
Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995).
U.S. Appl. No. 60/873,075, filed Dec. 5, 2006.
An International Preliminary Report on Patentability dated Nov. 9, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000357.
U.S. Appl. No. 60/902,146, filed Feb. 16, 2007.
An International Preliminary Report on Patentability dated Jun. 5, 2012, which issued during the prosecution of Applicant's PCT/IL2010/001024.
U.S. Appl. No. 61/001,013, filed Oct. 29, 2007.
An International Preliminary Report on Patentability dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000404.
U.S. Appl. No. 61/132,295, filed Jun. 16, 2008.
Notice of Allowance dated Apr. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/341,960.
“Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978.
An Office Action dated Mar. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
An Office Action dated Aug. 2, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291.
A Restriction Requirement dated Mar. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/785,717.
An International Search Report and a Written Opinion both dated Jun. 10, 2010, which issued during the prosecution of Applicant's PCT/IL09/01209.
An Office Action dated Jan. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An Office Action dated Apr. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
An Office Action dated Nov. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
A Notice of Allowance dated Sep. 16, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An International Search Report and a Written Opinion both dated Aug. 17, 2010, which issued during the prosecution of Applicant's PCT/IL10/00357.
An Office Action dated Sep. 16, 2009 which issued during the prosecution of U.S. Appl. No. 11/950,930.
Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999).
A Restriction Requirement dated Nov. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/926,673.
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001).
A Supplementary European Search Report dated Jan. 20, 2015, which issued during the prosecution of European Patent Application No. 12803037.6.
An International Preliminary Report on Patentability dated Jun. 29, 2011, which issued during the prosecution of Applicant's PCT/IL2009/001209.
Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000).
Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8 (3) (2005).
An International Search Report and a Written Opinion both dated Feb. 10, 2011, which issued during the prosecution of Applicant's PCT/IL10/00890.
Alfieri et al.“Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493.
A Notice of Allowance dated Jun. 26, 2012, which issued during the prosecution of U.S. Appl. No. 12/608,316.
A Notice of Allowance dated Jul. 30, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
An Office Action dated Jan. 23, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
An International Search Report dated May 19, 2011, which issued during the prosecution of Applicant's PCT/IL2011/00064.
A Supplementary European Search Report dated Feb. 1, 2011, which issued during the prosecution of European Patent Application No. EP 07849540.
An International Search Report together with Written Opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001024.
An Office Action dated Aug. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An Office Action dated Jul. 20, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
Notice of Allowance dated May 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
An Office Action dated Aug. 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
An Office Action dated May 10, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
An Office Action dated Mar. 9, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
A Restriction Requirement dated Sep. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,192.
Notice of Allowance dated Apr. 12, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
An Office Action dated Sep. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An International Search Report and Written Opinion dated Nov. 8, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000358.
An Office Action dated Dec. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
An International Search Report and a Written Opinion both dated Nov. 23, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000446.
An International Search Report with Written Opinion both dated Feb. 2, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000600.
An International Preliminary Report on Patentability dated Nov. 9, 2011 which issued during the prosecution of Applicant's PCT/IL2010/000358.
An Office Action dated Aug. 4, 2010, which issued during the prosecution of U.S. Appl. No. 12/341,960.
An Office Action dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
An Office Action dated Aug. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An Office Action dated Feb. 12, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
Notice of Allowance dated Dec. 7, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291.
A Restriction Requirement dated Oct. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
A Notice of Allowance dated May 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
A Restriction Requirement dated Jul. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
A Notice of Allowance dated Apr. 3, 2013, which issued during the prosecution of U.S. Appl. No. 12/563,930.
An Office Action dated Apr. 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717.
An Advisory Action dated Sep. 6, 2012 which issued during the prosecution of U.S. Appl. No. 12/548,991.
A Restriction Requirement dated Feb. 4, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606.
An Office Action dated Feb. 14, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,492.
An International Search Report and a Written Opinion both dated Feb. 22, 2013, which issued during the prosecution of Applicant's PCT/IL201/050451.
An Office Action dated Apr. 1, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,476.
A Restriction Requirement dated Jun. 7, 2013 which issued during the prosecution of U.S. Appl. No. 13/141,606.
An Office Action dated Aug. 23, 2013 which issued during the prosecution of U.S. Appl. No. 13/167,444.
U.S. Appl. No. 61/265,936, filed Dec. 2, 2009.
U.S. Appl. No. 61/283,445, filed Dec. 2, 2009.
U.S. Appl. No. 61/207,908, filed Feb. 17, 2009.
Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011).
An Office Action dated Dec. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,262.
Notice of Allowance dated Nov. 19, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An Office Action dated Oct. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An Office Action dated Nov. 21, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,476.
An Office Action dated Dec. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,141.
A Restriction Requirement dated Apr. 19, 2010 which issued during the prosecution of U.S. Appl. No. 12/341,960.
An Office Action dated Jun. 13, 2012, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An Office Action dated Nov. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
An Office Action dated Oct. 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
A Restriction Requirement dated Oct. 25, 2012 which issued during the prosecution of U.S. Appl. No. 13/167,444.
An Office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,444.
A Restriction Requirement dated Nov. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An International Preliminary Report on Patentability dated Feb. 4, 2014, which issued during the prosecution of Applicant's PCT/IL2011/000446.
A Supplementary European Search Report dated Dec. 4, 2012, which issued during the prosecution of European Patent Application No. EP 09834225.6.
A Supplementary European Search Report dated Mar. 28, 2013, which issued during the prosecution of European Patent Application No. EP 1077 2091.4.
U.S. Appl. No. 61/733,979, filed Dec. 6, 2012.
U.S. Appl. No. 61/717,303, filed Oct. 23, 2012.
U.S. Appl. No. 61/820,979, filed May 8, 2013.
U.S. Appl. No. 61/745,848, filed Dec. 6, 2012.
An Office Action dated May 19, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An Office Action dated Sep. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An Office Action dated Dec. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717.
An Office Action dated May 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
Amendment, Terminal Disclaimer and Extension dated Jun. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An International Preliminary Report on Patentability dated Jan. 29, 2013, which issued during the prosecution of Applicant's PCT/IL2011/000600.
An International Search Report and a Written Opinion both dated Dec. 6, 2012 which issued during the prosecution of Applicant's PCT/IL2012/000250.
An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 14/551,951.
U.S. Appl. No. 61/557,082, filed Nov. 8, 2011.
A Restriction Requirement dated Jul. 12, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An Office Action dated Mar. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412.
An Office Action dated May 6, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,693.
A Restriction Requirement dated May 1, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
Langer et al. Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation, The Journal of Thoracic Cardiovascular surgery vol. 133 No. 1, Jan. 2007.
Langer et al. Ring+String, Successful Repair technique for ischemic mitral regurgitation with severe leaflet Tethering, The Department of Thoracic Cardiovascular surgery, Hamburg, Germany, Nov. 2008.
U.S. Appl. No. 61/555,570, filed Nov. 4, 2011.
A Notice of Allowance dated Sep. 18, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
A Restriction Requirement dated Apr. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009).
An Office Action dated Oct. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
An Office Action dated Jul. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
An Interview Summary dated Jul. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
A Notice of Allowance dated May 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412.
An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694.
Search Report in European Patent Application 10772090.6 dated Jan. 17, 2014.
An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
Communication regarding amended claims filed dated Dec. 27, 2012, regarding European App No. 11792047.0.
Notice of Allowance dated Mar. 6, 2014, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An Office Action dated Oct. 9, 2013, which issued during the prosecution of U.S. Appl. No. 12/996,954.
AMPLATZER® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the AMPLATZER Septal Occluder System, AGA Medical Corporation, Apr. 2008.
Notice of Allowance dated Sep. 12, 2014, which issued during the prosecution of U.S. Appl. No. 11/950,930.
An Office Action dated Dec. 19, 2013, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An International Preliminary Report on Patentability dated Dec. 18, 2010, which issued during the prosecution of Applicant's PCT/IL09/00593.
An English translation of an Office Action dated Apr. 23, 2014 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
Notice of Allowance dated Jun. 23, 2014, which issued during the prosecution of U.S. Appl. No. 12/548,991.
Notice of Allowance dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
Notice of Allowance dated Jun. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/666,262.
An International Search Report and Written Opinion both dated Apr. 9, 2014, which issued during the prosecution of Applicant's PCT/IL13/50860.
An International Search Report & Written Opinion both dated May 12, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050914.
An Office Action dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934.
A Restriction Requirement dated Jun. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030.
Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008.
A communication from the European Patent Office dated Sep. 28, 2011 which issued during the prosecution of European Application No. 09834225.6.
A Restriction Requirement dated Sep. 17, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,693.
An Office Action dated Aug. 22, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Aug. 26, 2014 which issued during the prosecution of U.S. Appl. No. 13/167,444.
Communication dated Jul. 25, 2014, issued by the State Intellectual Property Office of the P.R. of China in counterpart Application No. 200980157331.3.
A Notice of Allowance dated Sep. 3, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
Communication from the European Patent Office dated Jun. 11, 2015, which issued during the prosecution of European Patent Application No. 11811934.
Supplementary European Search Report dated Oct. 23, 2014 which issued during the prosecution of Applicant's European App No. 10826224.7.
An International Search Report & Written Opinion both dated Mar. 21, 2014, which issued during the prosecution of Applicant's PCT/IL13/50992.
A Notice of Allowance dated Feb. 2, 2015, which issued during the prosecution of U.S. Appl. No. 13/504,870.
An Office Action dated Oct. 14, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030.
Alfieri et al., “The edge to edge technique,” The European Association for Cardio-Thoracic Surgery 14th Annual Meeting Oct. 7-11, Book of Procees. (2000).
An Office Action dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/504,870.
An Office Action dated Oct. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/749,153.
An International Search Report & Written Opinion both dated Sep. 8, 2009, which issued during the prosecution of Applicant's PCT/IL09/00593.
An International Search Report and a Written Opinion both dated Nov. 14, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000404.
Dictionary.com definition of “lock”, Jul. 29, 2013.
A Restriction Requirement dated Jan. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
A Restriction Requirement dated Nov. 14, 2011 which issued during the prosecution of U.S. Appl. No. 12/548,991.
An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050861.
A Notice of Allowance dated May 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,635.
An International Preliminary Report on Patentability dated May 1, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000890.
A Notice of Allowance dated Jan. 7, 2014, which issued during the prosecution of U.S. Appl. No. 12/926,673.
Restriction Requirement dated May 5, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
Supplementary European Search Report dated Aug. 4, 2014 which issued during the prosecution of Applicant's European App No. 11 81 1934.6.
An Office Action dated Aug. 5, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
An Office Action dated Feb. 17, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
Restriction Requirement dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/689,635.
Supplementary European Search Report dated Jan. 21, 2014 which issued during the prosecution of Applicant's European App No. 11 78 6226.
An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463.
Maisano, The double-orifice technique as a standardized approach to treat mitral . . . , European Journal of Cardio-thoracic Surgery 17 (2000) 201-205.
AMPLATZER® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008.
An Office Action dated Jun. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An Office Action dated May 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An Office Action dated Apr. 2, 2015, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Mar. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Supplementary European Search Report dated Dec. 23, 2014 which issued during the prosecution of Applicant's European App No. 10834311.
An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
An Office Action dated Mar. 23, 2015, which issued during the prosecution of European Patent Application No. EP 09834225.6.
Supplementary European Search Report dated Mar. 23, 2015, which issued during the prosecution of Applicant's European App No. 11792047.0.
Notice of Allowance dated Dec. 20, 2013, which issued during the prosecution of U.S. Appl. No. 12/437,103.
Supplementary European Search Report dated Apr. 29, 2015, which issued during the prosecution of Applicant's European App No. 14200202.
An International Preliminary Report on Patentability dated Dec. 23, 2014, which issued during the prosecution of Applicant's PCT/IL2012/050451.
An International Search Report and a Written Opinion both dated Apr. 15, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861.
An International Preliminary Report on Patentability dated Dec. 23, 2013, which issued during the prosecution of Applicant's PCT/IL2012/000250.
An Office Action dated Aug. 7, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050861.
An Invitation to pay additional fees dated Jan. 31, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050860.
An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694.
A communication from the European Patent Office dated Oct. 19, 2012 which issued during the prosecution of European Application No. 11792047.0.
An Office Action dated Oct. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/996,954.
An Office Action dated Oct. 5, 2015, which issued during the prosecution of U.S. Appl. No. 14/246,417.
An Office Action dated Oct. 1, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228.
Supplementary European Search Report dated Sep. 25, 2015, which issued during the prosecution of Applicant's European App No. 09794095.1.
An Office Action dated Apr. 7, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
An Office Action dated Jan. 13, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Mar. 16, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426.
European Search Report dated Jun. 24, 2016, which issued during the prosecution of European Patent Application No. EP 12847363.
An Office Action dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226.
An Office Action dated Jul. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated May 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,030.
An Office Action dated Jun. 13, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606.
An English translation of an Office Action dated Jul. 17, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
Notice of Allowance dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/141,606.
An International Search Report and a Written Opinion both dated Oct. 27, 2016, which issued during the prosecution of Applicant's PCT/IL2015/050792.
An International Preliminary Report on Patentability dated Jun. 9, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050992.
An Office Action dated May 3, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030.
A Notice of Allowance dated Sep. 2, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Feb. 3, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426.
Search Report in European Patent Application 10826224.7 dated Nov. 16, 2015.
Notice of Allowance dated Dec. 24, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
An English Translation of an Office Action dated Nov. 24, 2015, which issued during the prosecution of Israel Patent Application No. 223448. (the relevant part only).
Notice of Allowance dated Nov. 12, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
Notice of Allowance dated Jan. 7, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,007.
Notice of Allowance dated Apr. 20, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512.
Notice of Allowance dated Mar. 23, 2011, which issued during the prosecution of U.S. Appl. No. 12/484,512.
An Office Action dated May 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/209,171.
European Search Report dated Jul. 8, 2016, which issued during the prosecution of Applicant's European App No. 13849843.1.
Notice of Allowance dated Nov. 13, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
Notice of Allowance dated Feb. 19, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,192.
Notice of Allowance dated Nov. 23, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
An English translation of an Office Action dated Dec. 12, 2013 which issued during the prosecution of Chinese Patent Application No. 200980157331.3.
Notice of Allowance dated Nov. 17, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226.
European Search Report dated Nov. 4, 2015, which issued during the prosecution of European Patent Application No. EP 1077 2091.4.
Notice of Allowance dated Dec. 19, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151.
European Search Report dated Jul. 15, 2016, which issued during the prosecution of Applicant's European App No. 13849947.0.
An Office Action dated Jun. 17, 2016, which issued during the prosecution of U.S. Appl. No. 14/357,040.
Notice of Allowance dated Dec. 30, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030.
Notice of Allowance dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
Notice of Allowance dated Aug. 3, 2015, which issued during the prosecution of U.S. Appl. No. 13/749,153.
Notice of Allowance dated Dec. 9, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476.
Notice of Allowance dated Nov. 7, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492.
Notice of Allowance dated Jan. 22, 2015, which issued during the prosecution of U.S. Appl. No. 13/167,444.
An International Preliminary Report on Patentability dated Apr. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050860.
An Office Action dated Jan. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An Office Action dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
An Office Action dated Apr. 7, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151.
An Office Action dated Jan. 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
An International Preliminary Report on Patentability dated Jun. 10, 2009, which issued during the prosecution of Applicant's PCT/IL07/01503.
Notice of Allowance dated Aug. 19, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906.
An Office Action dated Jun. 8, 2012, which issued during the prosecution of U.S. Appl. No. 11/908,906.
An Office Action dated Dec. 21, 2013, which issued during the prosecution of U.S. Appl. No. 11/908,906.
A Restriction Requirement dated Aug. 5, 2011, which issued during the prosecution of U.S. Appl. No. 11/908,906.
An Office Action dated Oct. 23, 2012, which issued during the prosecution of Japanese Patent Application No. 2009-539871.
U.S. Appl. No. 60/662,616, filed Mar. 17, 2005.
U.S. Appl. No. 60/700,542, filed Jul. 18, 2005.
An Office Action dated May 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
An Office Action dated Jun. 14, 2016, which issued during the prosecution of U.S. Appl. No. 14/273,155.
An International Search Report and a Written Opinion both dated Jan. 25, 2016, which issued during the prosecution of Applicant's PCT/IL2015/051027.
An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426.
An International Preliminary Report on Patentability dated Apr. 26, 2016, which issued during the prosecution of Applicant's PCT/IL2014/050914.
An Office Action dated May 11, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An International Search Report and a Written Opinion both dated Sep. 12, 2008, which issued during the prosecution of Applicant's PCT/IL07/01503.
An English Translation of an Office Action dated Sep. 15, 2016, which issued during the prosecution of Israel Patent Application No. 243837. (the relevant part only).
Notice of Allowance dated Sep. 14, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Notice of Allowance dated Jul. 24, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Notice of Allowance dated Jul. 8, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
Ahmadi, Ali, et al. “Percutaneously adjustable pulmonary artery band.” The Annals of thoracic surgery 60 (1995): S520-S522.
Assad, Renato S. “Adjustable Pulmonary Artery Banding.” (2014).
Ahmadi, A., G. Spillner, and Th Johannesson. “Hemodynamic changes following experimental production and correction of acute mitral regurgitation with an adjustable ring prosthesis.” The Thoracic and cardiovascular surgeon36.06 (1988): 313-319.
Swenson, Orvar. “Internal device for control of urinary incontinence.” Journal of pediatric surgery 7.5 (1972): 542-545.
Park, Sang C., et al. “A percutaneously adjustable device for banding of the pulmonary trunk.” International journal of cardiology 9.4 (1985): 477-484.
Elliott, Daniel S., Gerald W. Timm, and David M. Barrett. “An implantable mechanical urinary sphincter: a new nonhydraulic design concept.” Urology52.6 (1998): 1151-1154.
An Invitation to pay additional fees dated Aug. 18, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050433.
Daebritz, S., et al. “Experience with an adjustable pulmonary artery banding device in two cases: initial success-midterm failure.” The Thoracic and cardiovascular surgeon 47.01 (1999): 51-52.
Notice of Allowance dated Mar. 1, 2017, which issued during the prosecution of U.S. Appl. No. 14/357,040.
An Office Action dated Sep. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
An International Search Report and a Written Opinion both dated Oct. 17, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050433.
An Office Action dated Oct. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/567,472.
Notice of Allowance dated Jul. 7, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
Notice of Allowance dated Nov. 18, 2016, which issued during the prosecution of U.S. Appl. No. 13/740,582.
Notice of Allowance dated Oct. 20, 2015, which issued during the prosecution of U.S. Appl. No. 12/996,954.
Amendment and Extension dated Apr. 11, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
Notice of Allowance dated Dec. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated Dec. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated Dec. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Notice of Allowance dated Jan. 3, 2017, which issued during the prosecution of U.S. Appl. No. 14/128,756.
Swenson, O. and Malinin, T.I., 1978. An improved mechanical device for control of urinary incontinence. Investigative urology, 15(5), pp. 389-391.
Swenson, O. An experimental implantable urinary sphincter. Invest Urol. Sep. 1976;14(2):100-3.
An International Preliminary Report on Patentability dated Sep. 18, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342.
An International Search Report and a Written Opinion both dated May 30, 2007, which issued during the prosecution of Applicant's PCT/IL2006/000342.
An Advisory Action dated Feb. 4, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,476.
An English Translation of an Office Action dated May 31, 2012, which issued during the prosecution of Israel Patent Application No. 209946. (the relevant part only).
A Restriction Requirement dated Jul. 8, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228.
Notice of Allowance dated Sep. 22, 2016, which issued during the prosecution of U.S. Appl. No. 13/740,582.
A Restriction Requirement dated Sep. 4, 2015, which issued during the prosecution of U.S. Appl. No. 14/589,100.
Notice of Allowance dated Jan. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/551,951.
An International Search Report and a Written Opinion both dated May 28, 2014, which issued during the prosecution of Applicant's PCT/IL14/050027.
An Office Action dated Aug. 22, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426.
An Office Action dated Dec. 20, 2016, which issued during the prosecution of UK Patent Application No. 1611910.9.
Notice of Allowance dated Aug. 7, 2015, which issued during the prosecution of Chinese Patent Application No. 200980157331.3.
An Office Action dated Jan. 20, 2017, which issued during the prosecution of U.S. Appl. No. 14/650,114.
An Office Action dated Feb. 10, 2017, which issued during the prosecution of U.S. Appl. No. 14/990,172.
An Office Action dated Feb. 2, 2017, which issued during the prosecution of U.S. Appl. No. 14/209,171.
An Office Action dated Jan. 25, 2017, which issued during the prosecution of Chinese Patent Application No. 201510681407.X.
An Office Action dated Dec. 13, 2016, which issued during the prosecution of Applicant's European App No. 11786226.8.
An Interview Summary dated Apr. 4 ,2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
An Office Action dated Mar. 3, 2017, which issued during the prosecution of Applicant's European App No. 11792047.0.
An Office Action dated Feb. 27, 2017, which issued during the prosecution of U.S. Appl. No. 15/249,957.
An Office Action dated Apr. 6, 2017, which issued during the prosecution of U.S. Appl. No. 14/437,062.
Notice of Allowance dated Apr. 13, 2017, which issued during the prosecution of U.S. Appl. No. 14/650,114.
An Office Action dated Mar. 24, 2017, which issued during the prosecution of U.S. Appl. No. 14/273,155.

Related Publications (1)

	Number	Date	Country
	20170196691 A1	Jul 2017	US

Continuations (1)

	Number	Date	Country
Parent	14141228	Dec 2013	US
Child	15444862		US

Implantation of flexible implant

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

US

CPC

International Classifications

Disclaimer

Term Extension

Abstract